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Summary
Mast cells with the morphological and biochemical properties of 
mucosal mast cells (MMC) appear and proliferate to form the 
predominant cell type in rat bone marrpw cultures stimulated with 
factors from antigen or mitogen-activated lymphocytes. This thesis 
has been divided into two sections; in the first section, a detailed 
examination was undertaken of the culture conditions required, 
including factor dependency, to cause the selective emergence and 
proliferation of MMC from normal bone marrow cultures. In the second 
section, the author has attempted to characterise the cells growing in 
culture using histological, morphological and immunohistochemical 
techniques.
Section 1_
Chapter 1_: This chapter describes experiments performed which led to
the adoption of the culture system that generates MMC in normal bone 
marrow cultures. It became apparent that immune mesenteric lymph node 
cells (IMLN) from Nippostronqylus brasiliensis (Nb.)-infected rats 
when stimulated in vitro with 2 pg/ml concanavalin A (Con-A) and the 
supernatant harvested after 48 hrs produced the most potent 
conditioned medium (CM) compared to conditioned media prepared from 
MLN cells of normal animals. Tritiated thymidine incorporation by the 
lymphocytes stimulated by Con-A could not be used as an indicator of 
potency for MMC growth stimulatory activity. CM is required at all 
times during the culture of normal bone marrow if MMC are to be 
stimulated to proliferate and be maintained as a viable population in 
vitro. A comparison was made of a number of different rat strains in 
their ability to produce potent CM and in their MMC bone marrow
response to CM from both syngeneic and allogeneic strains of rats. 
F344 rats consistently produced the most potent CM and also gave 
consistently higher numbers of mast cells in bone marrow cultures. 
This strain was therefore the one chosen for both CM and MMC 
production.
Chapter 2: In this chapter, the basis of the thymus-dependency of MMC
was explored. Fractionation experiments of the IMLN cells indicated 
that the mast cell growth factor(s) was produced by immunoglobulin 
negative cells, maximal mast cell growth was seen in those bone marrow 
cultures stimulated with CM prepared from the T cell-enriched fraction 
of IMLN cells. MMC growth factor was not produced by IMLN cells of 
athymic rats, by contrast MMC precursors were present in the bone 
marrow of athymic rats and were normally receptive to the growth 
factor produced by the lymphocytes of thymus-intact rats.
Chapter 3: Having demonstrated that the thymus-dependency of MMC
proliferation was based on the production of appropriate growth factor 
by the Con-A activated T cells present in IMLN of Nb.-infected rats, 
further definition of the source of MMC growth factor was provided by 
investigating the surface phenotype of the T cell producing the 
factor. Lymphocytes from the IMLN of Nb.-infected rats were separated 
on the fluorescence activated cell sorter into populations with and 
without the antigens defined by 0X19, W3/25 and 0X8 monoclonal 
antibodies: these antibodies label all T cells, T-helper cells and T-
cytotoxic/suppressor cells, respectively. The supernatants were 
tested for the ability to induce MMC growth and differentiation in 
bone marrow cultures. The phenotype of the factor producing T cell 
was established as belonging to the helper/inducer subset i.e. 0X19+,
v
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W3/25+ and 0X8“.
Chapter Ai When working in in vitro systems, it must be borne in mind 
how the observations made may relate to phenomena observed in vivo, or 
how the in vitro sytem may be used to dissect the mechanisms involved 
in certain reactions seen in vivo. The effect of corticosteroids on 
the mast cell response during Nb. infection was one such reaction 
investigated by the in vitro culture system. Dexamethasone was found 
to suppress MMC growth factor production' in vitro and also inhibit or 
arrest maturity of the mast cells growing in culture. This is 
discussed in the context of the phenomena observed in vivo.
Section _2
Chapter 5: The mast cells grown in culture from normal rat bone
marrow exhibited the generally accepted criteria for the definition of 
mast cells at all stages of development, in that the granules showed 
metachromasia when stained with toluidine blue at pH 0.5 but shared 
the property of MMC in that they required special fixation techniques. 
The cultured mast cells were positively stained with astra blue and at 
no time stained with safranin. Ultrastructurally the developing 
cultured mast cells exhibited some of the features of developing in 
vivo-derived MMC. They were smaller than the classic connective 
tissue mast cell (CTMC) and the granules were of variable size and 
electron density. The time course study of the mast cell development 
in culture followed the pattern of maturation seen for MMC in vivo. 
The relationship between the cultured cells, MMC and CTMC is 
discussed.
Chapter J5: The heterogeneity observed in mast cell populations is
difficult to define using anatomical location and detection or failure
vi
to detect glycosaminoglycans. In this chapter, the cultured mast 
cells were shown to be mucosal in nature as they stained exclusively 
with a monospecific antibody raised against the proteinase found in 
MMC, rat mast cell proteinase II (RMCPII). By determining the 
proteinase phenotype of the mast cell granules, an alternative and 
reliable approach to identifying mast cell subsets has been found. 
The cultured mast cells were found to contain and secrete RMCPII and 
had the proteinase phenotype of MMC.
A system is described in this thesis whereby in vitro analogues 
of MMC can be grown in vitro from normal rat bone marrow under the 
influence of T cell products. This provides an opportunity to answer 
hitherto intractable questions about the factors affecting MMC growth 
and differentiation and the opportunity to dissect phenomena observed 
in vivo by manipulating the conditions of culture. It also provides 
an abundant source of these cells for further characterisation.
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General Introduction
The first clear description of the mast cell was made by Paul 
Erlich in 1877 (reviewed in Michels, 1938). He described cells whose 
granules showed metachromasia when stained with aniline dyes such as 
methyl violet and dahlia and viewed through the light microscope. The 
cells were variable in size and appeared in various amoeboid-like 
shapes in situ in the tissues. Erlich observed that the mast cell was 
generally found in connective tissues near blood vessels, nerves and 
glandular ducts as well as in inflammatory and neoplastic foci. They 
have subsequently been found to be widely distributed throughout the 
tissues although in varying numbers. In human tissues, the mast cells 
are relatively abundant in skin, thymus, lymphoid tissue, uterus, 
urinary bladder, tongue, synovia, mesentery around large and small 
blood vessels, and in the subserosal and submucosal layers of the 
digestive tract. Moderate numbers are found in the medium sized blood 
vessels, testes, heart and pancreas whilst reduced numbers are present 
in the adrenal glands, hypothalamus and placenta. Mast cells are 
relatively infrequent in muscle, bone and cartilage although they can 
be found in the surrounding connective tissue (Selye, 1965).
Mast cells are known to be involved in many reactions most 
notably the type I immediate hypersensitivity reaction and delayed- 
type hypersensitivity reaction (Metcalfe, Kaliner and Donlon, 1981; 
Askenase and Van Lovem, 1983). They have also been implicated in the 
pathogenesis of many disease states. Mast cells of the 
gastrointestinal tract have long been suspected of playing a 
physiological role in the function of this tissue and are involved in 
a number of inflammatory processes, including the response to 
parasitic infection, gastrointestinal allergy and chronic inflammatory 
diseases of the bowel (Bienenstock, Befus, Pierce, Denburg and
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Goodacre, 1982; Lemanske, Atkins and Metcalfe, 1983; Barrett and 
Metcalfe, 1984). The in situ histochemical studies describing the 
distribution and characteristics of the cells in normal and diseased 
tissue (Norris, Zamcheck and Gottlieb, 1963; Lloyd, Green, Fox, Mani 
and Tumberg, 1975; Strobel, Miller and Ferguson, 1981) along with the 
electron microscopic analysis of Crohn's disease indicate mast cell 
numbers can increase, and degranulation occur thus suggesting that 
mast cell mediators are involved in the pathogenesis of inflammatory 
bowel disease (Ranlov, Nielson and Wanstrup, 1972; Dvorak, Monahan, 
Osage and Dickersin, 1980). The increased prevalance of mast cells in 
rheumatoid synovium, pannus, and bone in rheumatoid arthritis has 
still to be evaluated but circumstantial evidence points to these 
cells being implicated in the pathogenesis of this disease also 
(Crisp, 1984).
A rapidly increasing body of evidence now firmly indicates that 
mast cells from different species, and from different tissues within 
the same animal exhibit marked variations in their morphological, 
cytochemical and functional properties (Michels, 1938; Enerback, 1966a 
and b; Kaliner, 1980; Pearce, 1982; Bienenstock, Befus, Denburg, 
Goodacre, Pearce and Shanahan, 1983; Jarrett and Haig, 1984). Most 
functional studies have been done with mast cells from rodents, and 
their tissues contain at least two distinct types of mast cell that 
differ in morphology, histochemical staining properties and location 
(Jarrett and Haig, 1984). Mast cells in the peritoneal cavity 
represent the connective tissue mast cell (CTMC). The other type is 
referred to as the mucosal mast cell (MMC) which is found in the 
lamina propria of the gastrointestinal tract and other mucous
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membranes and is capable of rapidly increasing in number during 
certain immune reactions. The hyperplasia of MMC is one of the most 
striking cellular responses which occurs during helminth infection 
(Miller and Jarrett, 1971). The nature of the proliferative signals 
and origin of MMC has been the subject of much investigation.
Like mast cells, basophils were first recognised by Erlich in the 
late nineteenth century and were clearly distinguished by him from the 
fixed tissue mast cell (Michels, 1938), but because of similarities in 
the metachromatic staining properties and chemical composition of 
their granules, the clear distinction has sometimes become blurred. 
Basophils, unlike mast cells, are polymorphonuclear leukocytes which 
differentiate in the bone marrow, circulate in the blood and are 
capable of migrating into the tissues (Simpson and Ross, 1972; Dvorak 
and Dvorak, 1974). As well as the morphological differences, the 
origin, growth and differentiation of these two cell types is entirely 
separate. The origin of the tissue mast cell will be discussed at 
length later but suffice to say that mast cells are not found in the 
circulation and do not appear in progressive stages of development in 
the bone marrow although the precursor cells originally arise in the 
bone marrow (Kitamura, Shimada, Hatanaka and Miyano, 1977). The 
absence of recognisable mast cells in the blood implies that such 
precursors migrate to the tissues where they differentiate into mast 
cells. The basophils are present in the marrow in progressive stages 
of development and most likely arise from a stem cell in the bone 
marrow common to the other polymorphonuclear leucocytes, the 
eosinophil and neutrophil. The immature basophils arise in the bone 
marrow and undergo differentiation into mature cells that enter the 
blood but do not leave the circulation to enter the tissues under
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normal circumstances. Basophils can however be recruited to the 
tissues as part of specific immunopathologic processes as well as 
increasing in numbers in the blood e.g. responses to parasites in the 
skin and gastrointestinal tract (Miller, 1969; Askenase, 1977; 
Ogilvie, Askenase and Rose, 1980). There is no evidence that 
basophils or mast cells are derived from each other, but because of 
the obvious working relationship between them their role in different 
allergic disease states has to be considered.
Because of the mast cell's increasingly recognised role in a 
variety of diseases the question of heterogeneity and control of 
proliferation and differentiation is crucial to our understanding of 
mast cell function. In this study, in vivo phenomena have been 
transferred to an in vitro model whereby rat bone marrow is cultured 
under the influence of various factors from lymph nodes of helminth 
infected animals. The resultant cells are then studied for their 
origin, differentiation, morphological and functional 
characterisation.
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Review of the Literature
Mast cell heterogeneity
The existence of distinct subpopulations of mast cells was 
recognised by Maximow in 1906 and reviewed by Michels in 1938 but it 
wasn't till 1966 that a full systematic study of these subpopulations 
was performed by Enerback (1966a-d) who demonstrated the existence of 
"atypical" mast cells or mucosal mast cells (Mayrhofer, Bazin and 
Go wans, 1976) in the intestinal mucosa of the rat (Enerback, 1966a-d). 
These cells differ morphologically and histochemically from connective 
tissue mast cells which, when isolated from the peritoneal cavity, are 
the cells most used to study mast cell physiology and pharmacology. 
MMC were previously overlooked because of the special fixation 
procedures required for their demonstration in tissue sections 
(Enerback, 1966a). Mast cell heterogeneity in other species including 
humans (Strobel, Miller and Ferguson, 1981) has also been studied.
MMC and CTMC share the familiar staining characteristic of mast 
cells, namely metachromasia and dye-binding at very low pH levels, 
indicating the presence of sulphated glycosaminoglycans in the 
granules. However, the granules of MMC have a higher affinity for the 
copper pthalocyanine dyes such as alcian or astra blue at pH 0.3 in 
the astra blue/safranin sequence, while those of mature CTMC stain 
red: this distinction between blue and red is based on granule
contents of weakly and strongly sulphated mucopolysaccharides 
respectively (Enerback, 1981). Staining properties cannot, however, 
be used as grounds for distinguishing these two subclasses of cell 
categorically because immature CTMC stain positively with alcian blue 
and become progressively more positive for safranin as they mature, 
until they are exclusively stained by safranin (Combs, Lagunoff and
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Benditt, 1965). The indication from these findings and from the 
investigation by Miller and Walshaw (1972) who showed that 
alcianophilia of MMC granules was extinguished at a lower critical 
electrolyte concentration than that of the CTMC granules, was that the 
acid mucopolysaccharides of MMC were iess strongly sulphated than 
those of CTMC. Confirmation of this was obtained by Tas and Bemdsen 
(1977) who used a microspectrophotometric technique to demonstrate the 
absence of significant amounts of heparin in MMC and the presence of a 
lower sulphated glycosaminoglycan. Recently Enerback and colleagues 
(1985) have shown that the major polysaccharide produced by the rat 
MMC in vivo is an over sulpha ted galactosaminoglycan rather than 
heparin. They' injected inorganic [^S] into rats infected with Nb. 
and showed that the 5-fold increase in MMC was accompanied with a 
similar yield in labelled intestinal glycosaminoglycan. Analysis of 
the labelled material showed that 60% was oversulphated 
galactosaminoglycan whereas only 0.3% was heparin-related 
polysaccharides.
Further evidence of a difference between MMC and CTMC in the rat 
has been demonstrated by Woodbury and colleagues who have identified 
variant serine proteases in the two types of rat mast cells (Woodbury 
and Neurath, 1981). The first being rat mast cell protease I 
(RMCPI) originally isolated from skeletal muscle and found to be 
identical to that subsequently isolated from peritoneal mast cells. 
The second, a mast cell protease differing in solubility, structure 
and antigenicity from the first, was localised to mast cells in the 
small intestine and named RMCPII. Both are chymotrypsin-like in 
substrate specificity and molecular weight but are unusual in having 
relatively basic iso-electric points. Despite having a 75% sequence
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identity in their first 52 amino-terminal residues (Woodbury, Everitt, 
Sanada, Katunuma, Lagunoff and Neurath, 1978), they apparently do not 
cross-react immunologically (Woodbury, Gruzenski and Lagunoff, 1978), 
as tested by gel diffusion. However, there is strong cross reactivity 
both by immunohistochemistry and by Western blotting but this can be 
eliminated by affinity chromatography (Gibson and Miller, 1986), The 
relatively high solubility of RMCPII is associated with the systemic 
release of this enzyme in rats primed with Nb. and challenged 
intraduodenally with the homologous parasite (Miller, Woodbury, 
Huntley and Newlands, 1983). The presence of these proteases as 
detected by specific antibodies and quantification by immunoassay, 
provides an alternative approach to identification of MMC and CTMC in 
the rat, as well as selectively monitoring the secretory activity of 
MMC in this species.
The above studies have been confined to the rat, but as MMC have 
been implicated in a range of diseases and allergic disorders in man 
as well as in helminth infections in laboratory and domestic animals, 
it was considered important to examine whether similar MMC enzymes 
were present in other species. By using enzyme histochemical methods 
for the demonstration of esterases within MMC of rat, mouse, sheep and 
man, serine esterases were detected in the granules of all four 
species and the mast cell identity confirmed by sequential staining 
with toluidine blue (Huntley, Newlands, Gibson, Ferguson and Miller, 
1985). Although the function of these MMC enzymes remains unknown, 
the presence of similar chymotrypsin-like serine esterases within MMC 
of all four species studied suggests an important role for these 
enzymes.
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Mast cells in biological reactions
Mast cells contain many biologically active substances; these are 
released and new mediators are generated as the end result of membrane 
activation. The diverse group of highly active pharmacologic 
materials released or generated by these cells possess all the 
necessary properties for a fully expressed but controlled local 
inflammatory response. They can be broadly grouped into vasoactive, 
chemotactic and enzyme moieties, depending on their physical 
properties and their action on surrounding tissue. It is also 
possible to group mast cell mediators into categories on the basis of 
their being preformed in the cell or subsequently generated by the 
cell after activation (Kaliner, 1980). The granule-associated 
preformed mediators released from the cell as an initial reaction are: 
histamine which is stored in secretory granules and is associated by 
ionic linkage with carboxyl groups of heparin (Uvnas, Aborg and 
Bergendoff, 1970); serotonin, which is stored in secretory granules of 
mast cells in rat and mouse (Benditt, Wong, Arase and Roeper, 1955); 
dopamine, being found in the mast cells of ungulates (Falck, Nystedt, 
Rosengren and Stenflo, 1964); the chemotactic polypeptides, eosinophil 
chemotactic factors of anaphylaxis (ECF-A), and in man, a neutrophil 
chemotactic factor of anaphylaxis (NCF-A) (Wintroub and Sotar, 1981). 
The stimulated mast cell then releases a number of mediators which 
augment the immediate effect of the above substances viz: various 
proteases and heparin. There is evidence that the heparin 
proteoglycan of rat CTMC and, by extension, the chondroitin sulphates 
of the rat MMC, by virtue of their charge and density, function as the 
storage matrix in the mast cell granule for histamine, enzymes and 
chemotactic factors (Uvnas, 1978). Heparin also acts as an
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anticoagulant (Rosenberg, Armand and Lam, 1978) as well as inhibiting 
the alternative complement pathway (Weiler, Yurt, Fearon and Austen, 
1978).
The RMCPI neutral protease with chymotrypsin-like activity 
characteristically present in rat CTMC has a tight ionic association 
with heparin and this results in the inhibition of protease activity 
against some macromolecule substrates. The proteases augment 
inflammation with rat mast cell protease II (RMCPII) being released 
very rapidly from mast cells in intestinal mucosa challenged with 
parasite worm antigen and being implicated in the generation of 
increased mucosal permeability (Miller et al, 1983; King and Miller, 
1984).
Secondary mediators encompass those substances such as 
prostaglandins, leukotrienes and thromboxanes which are newly 
generated by mast cells as a direct result of their activation or are 
elicited from other cell types by the action of mast cell products. 
These mediators have agonist effects on microvasculature, smooth 
muscle, and inflammatory cells and can also act on mast cells to 
perhaps modulate the intensity of the initial activating event. Slow 
reacting substances of anaphylaxis (SRS-A) consists of leukotrienes 
C4, D4 and E4 (Murphy, Hammarstrom and Samuelsson, 1979; Lewis, 
Austin, Drazen, Clark, Marfat and Corey, 1980a; Lewis, Drazen, Austen, 
Clark and Corey, 1980b). The heterogeneity of mast cells is again 
emphasised by the diverse production of the arachidonate metabolites 
by the different cell types. The heparin containing mast cells: rat 
CTMC releasing PGD2  (Lewis, Sotar, Diamond, Austen, Oates and Roberts, 
1982); mouse CTMC releasing very small amounts of PGD2  and LTC4  
(Dubuske, Stevens, Lewis and Austen, unpublished observation); human
9
lung mast cells releasing approximately equal amounts of PGD2  an£^  LTC4  
(Paterson, Wasserman, Said and Austen, 1976; Lewis et al, 1982). The 
non-heparin containing cells on the other hand: the rat basophilic
leukaemia cell line identified as MMC-like (Seldin, Adelman, Austen, 
Stevens, Hein, Caulfield and Woodbury, 1985) releases substantially 
more LTC4  than PGD2  with culture-derived mouse mast cells also 
releasing much more LTC4  than PGD2  (Razin, Mencia-Huerta, Lewis, Corey 
and Austen, 1982). These metabolites of arachidonic acid can cause 
increased vascular permeability, potentiation of oedema and pain, 
chemotaxis of inflammatory cells and bronchoconstriction. 
Vasodilation is also maintained by these mediators in the later stages 
of the immediate allergic reactions (Lewis and Austen, 1984).
There exist many diverse agents that can provoke mast cells to 
degranulate and release mediators. The best known of these is the 
reaction of IgE antibodies with specific antigen on the surface of the 
cell. Antigen-dependent cross-linking of IgE which is fixed to mast 
cell plasma membrane receptors via its Fc region is necessary for 
degranulation to occur (Ishizaka, Chang, Taggart and Ishizaka, 1972). 
The sequence of biochemical events occurring in the target cell 
following antigen bridging of IgE molecules on the surface membrane 
involves extracellular Ca++ and cyclic AMP as well as esterase 
activity. In some instances other classes of immunoglobulin molecules 
can trigger mast cell mediator felease but the affinity of the 
antibodies for receptors on the cell is much less than that of IgE. 
Subpopulations of mast cells do not function identically in response 
to secretagogues and the ability of drugs to inhibit secretion also 
varies with the mast cell population. In a direct comparison of
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isolated rat CTMC and MMC, disodium cromoglycate and theophylline 
inhibited antigen-induced histamine release from CTMC but not from MMC 
while doxantrazole inhibited release from both populations (Pearce, 
Befus, Gauldie and Bienenstock, 1982). The chemical detergent 
compound 48/80 causes degranulation of CTMC but not MMC in the rat, 
and is not effective in degranulating human lung mast cells 
(Caulfield, Lewis, Hein and Austen, 1980; Befus, Pearce, Gauldie, 
Horsewood and Bienenstock, 1982). Cultured mouse mast cells release 
granule mediators in response to immunological activation (Razin, 
Mencia-Huerta, Stevens, Lewis, Liu, Corey and Austen, 1983) and 
ionophores (Razin, Mercia-Huerta, Lewis, Corey and Austen, 1982), but 
not to compound 48/80 (Sredni, Friedman, Bland and Metcalfe, 1983). 
Activation of either alternative or classical pathways of complement 
can also generate factors (C3 a and C^a) which stimulate mediator 
release (Wintroub and Soter, 1981). Mast cells and their products are 
uniquely suited to their function in the facilitation of removal of 
foreign organisms or endogenous tissue breakdown products by 
augmentation of local venular permeability and enhancement of ingress 
and function of host cells.
Allergic reactions in helminth infection
Helminth parasite infection stimulates a broad based immune 
response involving humoral and cell mediated mechanisms. Common to 
virtually all helminth infections, are raised levels of antigen 
specific and non-specific IgE, the occurrence of immediate allergic 
reactions and an associated increase in the number of mast cells, 
basophils and eosinophils (Jarrett and Miller, 1982).
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Nippostronqylus brasiliensis infection in rats
One of the most researched of all host-helminth relationships 
which exemplifies the IgE and associated cellular responses, is the 
infection of rats with N. brasiliensis (Nb.). This nematode parasite 
has a rapid life cycle, well documented pathological and immunological
effects on the host, and is not infective for man. Rats recover
rapidly and completely from a moderate infection.
Nb. is an intestinal nematode parasite of the rat. The infective
larval stages (L3 ) penetrate the skin of the host, migrate via the 
bloodstream to the lungs where they undergo a moult to the L4 stage. 
They are then coughed up and swallowed and 4-5 days after initial 
infection form a population of adult worms inhabiting the upper 
portion of the small intestine (Ogilvie and Love, 1974). Ten days 
after infection the parasites start to be expelled and this reaction 
is complete by day 14 after infection (Jarrett, Jarrett and Urquhart, 
1968).
The IgE response in N. brasiliensis infection
Parasite non-specific IgE is produced in infected rats before the 
antigen specific response can be detected (Orr and Blair, 1969; 
Jarrett and Bazin, 1974). The potentiated IgE response to egg albumin 
reaches a peak 12-14 days after infection synchronously with elevation 
of total IgE (Jarrett and Bazin, 1974). Nb.-specific IgE rises to a 
peak some 2-3 weeks later when both total IgE and the potentiated 
response have largely declined. Following reinfection, the parasite- 
specific IgE level rises steeply to around day 6  after infection 
followed by a slow decline (Jarrett, Haig and Bazin, 1976). The total
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IgE level however, although boosted simultaneously with the specific 
IgE response, declines rapidly after reinfection (Jarrett, Haig and 
Bazin, 1976). As with all IgE responses the effect is highly T cell 
dependent (Jarrett and Ferguson, 1974; Jarrett, Haig and Bazin, 1976).
An extensive series of experiments was carried out in the 
Ishizakas' laboratory to study the soluble IgE regulatory factors 
produced by T cells. In fact IgE itself is involved in the regulation 
of IgE production. In vitro studies have identified several IgE 
binding factors secreted by lymphocytes of Nb. -infected rats. Around 
days 12-14 of an infection there is an increase in IgE bearing B cells 
in the MLN and spleen. These cells also exhibited IgD and IgM on 
their surface and produce IgE B cell generating factor which stimulates 
differentiation of IgM bearing cells to E, M and D triple bearing 
cells (Urban, Ishizaka and Bazin, 1980). It was postulated that 
factor production could be triggered by the cross-linking of IgE 
molecules by antigen on the B cell surface (Urban, Ishizaka and 
Ishizaka, 1978).
Yodoi and Ishizaka in 1979 discovered another subpopulation of T
and B cells bearing Fc receptors for IgE (Fc R+ cells) in
c
Nb.-infected rats. Associated with an increase in number of these 
cells was an elevation of IgE levels (Spiegelberg, 1981). In vitro 
studies of potentiation of IgE (Suemara and Ishizaka, 1979) have shown 
that FCgR+ T cells are the source of potentiating factor which binds 
to IgE B cells and stimulates IgE production (Suemara, Yodoi, 
Hirashima and Ishizaka, 1980; Yodoi, Hirashima and Ishizaka, 1980). 
IgE suppressive factor was found to abrogate the effect of the 
potentiating factor (Hirashima, Yodoi and Ishizaka, 1980).. Both
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factors have also been produced by in vitro culture of MLN cells from 
rats injected with B. pertussis or complete Freund's adjuvant 
(Hirashima, Yodoi and Ishizaka, 1980). Subsequently various T and B 
cell-derived factors were discovered by the use of a Nb.-infected rat 
culture system and these factors are now thought to be involved in the 
control of IgE synthesis in allergy (Ishizaka, Yodoi, Suemara and 
Hirashima, 1983).
Cellular responses in helminth infection
Since Taliaferro and Sarles (1939) first reported the involvement 
of what they termed connective tissue basophils and eosinophils in the 
mucosal response to Nb. several studies have documented the mast cell 
response in mice and rats (Askenase, 1977; 1980; Miller and Jarrett, 
1982). In Hooded Lister rats infected with Nb. an exponential 
increase in mast cell numbers occurs between days 1 0  and 14 of a 
primary infection (Miller and Jarrett, 1971). However, the role of 
mast cells in immune expulsion is controversial as in some strains of 
rats these cells are only detectable following worm expulsion 
(Askenase, 1980). Anamnestic elevation of MMC numbers in parallel 
with worm expulsion occurs following reinfection (Mayrhofer, 1979). 
The anamnestic response of mast cells indicates the immunological 
control under which the cell responds to a stimulus. Detailed light 
and electron microscopic studies have demonstrated in rats harbouring 
the nematode Nfc\ that MMC arise from undifferentiated blast cells 
(Miller, 1971) and these findings agree well with the much earlier 
light microscopy study of Taliaferro and Sarles (1939).
Metachromatically stained granular cells can also be seen, in the
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epithelium of the small intestine of parasite-infected rats when 
stained with toluidine blue, these were termed globule leucocytes. 
These cells and their relationship to mast cells was studied 
extensively in the Nb. infected rat. The overwhelming conclusion 
reached was that globule leucocytes were mast cells that had migrated 
to the epithelium and degranulated (Murray, Miller and Jarrett, 1968; 
Miller, 1980).
The relationship between globule leukocytes and MMC in mice is 
less well defined. In normal mice, there are few MMC in the lamina 
propria, whereas cells containing basophilic granules (globule 
leukocytes) predominate in the epithelium in normal and parasitized 
mice (Askenase, 1980). A further cell type complicates the issue in 
mice, in that a subpopulation of intraepithelial lymphocytes has been 
shown to be granulated and to stain similarly to MMC, a precursor 
relationship of these granulated intraepithelial lymphocytes to MMC 
has been suggested (Guy-Grand, Griscelli and Vassalli, 1978).
A practical involvement for mast cells in helminth infection has 
unfolded. In Nb. infection, a mast cell-mediated local anaphylactic 
reaction in the gastrointestinal tract is thought to increase vascular 
permeability, allowing protective antibodies, cells and lymphokines 
access to the worms. The concept of such a "leak lesion" was put 
forward by Urquhart and colleagues (Urquhart, Mulligan, Eadie and 
Jennings, 1965; Barth, Jarrett and Urquhart, 1966). The detection and 
assaying of the secreted neutral proteinase RMCPII from MMC has 
allowed direct measurement of MMC activity. The release of this 
enzyme into the blood of rats infected with N^ brasiliensis and 
T. spiralis has been described (Woodbury, Miller, Huntley, Newlands, 
Palliser and Wakelin, 1984). In the T^ spiralis infected rats, the
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majority of adult worms were expelled from the intestine between 9 and 
12 days after infection. Mucosal mastocytosis was maximal at day 12 
with peak concentrations of enzyme in the serum being detected on this 
day also. Nb. worms were expelled from infected rats 10-12 days after 
infection. Maximal MMC hyperplasia occurred on day 12 with maximal 
accumulation of RMCPII on day 13 in the jejunal mucosa. The lag of 
RMCPII accumulation in the jejunal mucosa behind maximal mastocytosis 
suggested MMC secrete rather than store the enzyme. Recently it has 
been demonstrated that the granule product of MMC, RMCPII, is secreted 
systemically in Nb.-primed rats challenged with soluble worm antigen 
(Miller, Woodbury, Huntley and Newlands, 1983) and the gut is the 
major source of the systemically secreted enzyme (King, Miller, 
Woodbury and Newlands, 1986). King and Miller (1984) showed that 
there was a significant correlation between systemic and enteric 
secretion of RMCPII and the enteric accumulation of Evan's blue after 
intravenous challenge of Nb.-primed rats with whole worm antigen. The 
results indicated that RMCPII could have a role in altering intestinal 
mucosal permeability during systemic anaphylaxis in the rat (King and 
Miller, 1984). These findings support the concept that mast cells 
have a functional role in nematode expulsion.
It was reported that in Nb.-infected rats, basophils in 
peripheral blood increased from 0.06% to 4.5% of total leukocytes 13 
days after primary infection. Following reinfection, basophilia 
occurred more rapidly peaking at 5 days (Ogilvie, Hesketh and Rose, 
1978). Miller (1969) observed that basophils increase in number in 
the small intestine from around day 8 onwards, peaking at the time of 
worm expulsion and declining thereafter. The basophil was thus a
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prime candidate for an early anaphylactic response in the gut during 
expulsion whereas the mast cell role had been more controversial as 
mentioned previously. However, no evidence of basophil mediated 
anaphylaxis under these circumstances has been uncovered.
Eosinophils are much more abundant in the bone marrow, blood and 
the tissues of normal animals than basophils or mast cells. In mice 
and rats they have been shown to respond to parasite infection. Spry 
(1971) demonstrated that during Trichinella spiralis infection in 
rats, eosinophils arise from precursors in the bone marrow where they 
mature and travel via the bloodstream to the sites of inflammation. 
The response of eosinophils to stimulation is under T cell control 
(Walls, 1976) and an anamnestic eosinophil response to helminth 
infection can be demonstrated. As with mast cells, basophils and 
raised IgE levels, it has been difficult to ascribe any function to 
these cells in vivo. In vitro, however, eosinophils along with 
macrophages and neutrophils have been shown to attack and kill 
schistosomula in the presence of specific antibodies with or without 
complement (Askenase, 1980). Capron and colleagues have demonstrated 
that rat IgE antibody complexed to schistosome antigen binds to 
macrophages via an Fc receptor. The macrophage becomes activated and 
is capable of destroying schistosomula (Capron, Dessaint, Capron and 
Bazin, 1975; Dessaint, Capron, Joseph and Bazin, 1979). Rat 
eosinophils have also been demonstrated to kill schistosomula in vitro 
in the presence of parasite-specific IgG antibodies and complement 
(MacKenzie, Ramalho-Pinto, McLaren and Smithers, 1977; Ramalho-Pinto, 
McLaren and Smithers, 1978). The presence of mast cells has been 
shown to be required by eosinophils for the killing of schistosomula 
(Capron, Capron, Torpier, Bazin, Bout and Joseph, 1978). There is.
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therefore, an intimate relationship between mast cells, basophils, 
eosinophils and IgE levels in parasite infection.
T cell control of mast cells
Low but near normal numbers of MMC are present in uninfected 
athymic animals (Mayrhofer and Bazin, 1981) so that at a basal level 
the progression from stem cell to this specialised cell would appear 
to be without the benefit of the normal complement of T cells, 
although some reports have been published to the contrary. Olsen and 
Levy (1976) noted a marked deficiency of MMC in nu/nu mice with no 
increase in MMC following Nb. infection, whereas previously, Jacobson 
and Reed (1974) showed Nb. worms persisting in nu/nu mice confirming 
the T dependancy of immune expulsion. It has been shown in mice 
infected with T. spiralis that the hyperplasia of MMC that occurs in 
helminth infection requires T cells (Ruitenberg and Elgersma, 1976). 
Wakelin and colleagues have analysed the T cell control of the 
effector cells of bone marrow origin in the protective response 
against parasitic nematodes (Wakelin, 1980; Wakelin and Donachie, 
1980, 1981, 1983; Alizadeh and Wakelin, 1982), as well as the genetic 
control of the response to T^ spiralis in mice. MLN cells transferred 
from immune slow responder BIOG mice to normal BIOG mice, which would 
normally expel T. spiralis by day 16, accelerated expulsion of worms 
from recipients only by day 12. However, transfer of the same cells 
to rapid responder NIH mice accelerated expulsion of the parasite by 
day 8 of infection. The reciprocal transfer of IMLN cells from NIH to 
BIOG mice again resulted in expulsion by day 12 (Wakelin and Donachie, 
1980). Therefore the rapidity of response by the recipient to
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adoptive immunization was not a function of the transferred cells but 
rather of the environment into which they were transferred. The slow 
response was found to be determined by cells derived from the bone 
marrow (Wakelin and Donachie, 1981). Suggestion was made of genetic 
control of expulsion being expressed by the cells involved in the 
generation of the intestinal inflammatory response, and a recipient 
derived cooperating lymphocyte; one of the bone marrow derived 
components being the mast cell. Alizadeh and Wakelin (1982) showed 
mastocytosis was more rapid in onset and more intense in NIH than BIO 
strains of mice infected with T. spiralis. The onset of mastocytosis 
was again determined by cells of bone marrow origin following 
reciprocal transfer of lymphocytes between NIH and BIOG mice and 
radiation chimaeras. These in vivo studies suggested that mucosal 
mast cells differentiated from bone marrow cells through the influence 
of factors originating from T cells (Alizadeh and Wakelin, 1982). In 
the rat, infestation with Nb. also causes an increase in gut MMC. 
Nawa and Miller (1979) showed that an accelerated intestinal mast cell 
response could be transferred with immune cells from thoracic duct 
lymph, or the T cell fraction (surface Ig“), but not the B cell 
fraction (surface Ig+) of these cells. Increasing numbers of T cells 
induced progressively greater intestinal mast cell responses. Cells 
obtained 10 days after infection were optimal, and antigenic 
stimulation provided by infection of the recipients was necessary. 
The MMC response was shown to be absent in rats subjected to drainage 
of thoracic duct lymph plus thymectomy (2-12 weeks), but could be 
restored by transfer of cells from thoracic duct lymph (Mayrhofer, 
1979; Mayrhofer and Fisher, 1 979). It was not known at this time if
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stimulation of these T cells by the worm antigen was leading to direct 
transformation of the cells into mast cells or if factors produced by 
them were exerting an inductive influence on MMC precursors. An 
investigation of the proliferation and development of MMC will form a 
part of this thesis.
Mast cells in vitro
Many investigators have attempted to determine the origin of mast 
cells and the factors affecting their development by in vitro culture 
methods.
Mast cells have been cultured from many different cell 
populations within the haemopoietic and lymphoid tissues. As far back 
as 1963, Ginsburg and Sachs had grown pure suspensions of mast cells 
from thymocytes seeded onto mouse embryo fibroblast layers. The 
transformation had occurred over a period of two months and was 
dependant on the presence of the feeder layer. Subsequently, it was 
found that mesenteric lymph node and thoracic duct cells from mice 
hyperimmunised with horse serum developed into mast cells when grown 
oyer a mouse embryo fibroblast feeder layer in the presence of 
homologous antigen (Ginsburg and Lagunoff, 1967). Pursuing these 
earlier studies it was found that two types of mast cells arose in 
such cultures: one type, not dependant on T-cell factors, arose from
the cells in the fibroblast monolayer; while the other type dependant 
on the presence of T cells or their products and resembling MMC, arose 
from a precursor in the lymphoid layer (Ginsburg, Ben-Shahar and Ben- 
David, 1982). Mast cells derived from the former are generally 
large and contain small homogenous granules whereas mast cells derived
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from lymphoid tissue appear smaller and contain fewer and more 
irregular granules. In the rat, cultures of rat thymus showed that 
both thymus cells and feeder layers could develop into mast cells 
(Ishizaka, Okudaira, Mauser and Ishizaka, 1976).
In vitro, mouse mast cell lines with the biochemical and 
cytological properties of MMC have been grown (Sredni et aly 1983). 
The aforementioned authors cloned histamine-containing granulated 
cells from mouse bone marrow using sequential soft agar and limiting 
dilution techniques. They could differentiate between basophils, CTMC 
and MMC on functional, morphological and biochemical parameters. 
Ultrastructural criteria were relied on heavily for this distinction. 
The cloned cells bound and had an affinity for monomeric IgE similar 
to that of normal mast cells. They failed to ingest latex particles 
and contained histamine. These characteristics being consistent with 
the cells being basophils, CTMC or MMC. Morphologically they 
resembled mast cells rather than basophils, having thin, elongated 
microvilli or plasmalemmal ridges in contrast to short villi and blunt 
processes reported in mouse basophils (Dvorak, Nabel, Pyne, Cantor, 
Dvorak and Galli, 1982). The histamine-containing granulated cells 
possess the ultrastructurally distinct cytoplasmic granules found in 
cultured mouse mast cells, as well as the heterogeneity of size of 
granule which can fill the cytoplasm and which is not seen in 
basophils. The proteoglycans and glycosaminoglycans produced by the 
histamine-containing granulated cells were shown to be chondroitin 
sulphate, which is oversulphated, and not heparin which is present in 
CTMC. Their failure to respond to compound 48/80 is consistent with 
these cells being MMC.
Mast cells can be maintained in proliferation for prolonged
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periods in the presence of the appropriate factor. . The latter is 
associated with a lymphokine identified in the' supernatant of Con-A 
stimulated T cells (Nabel, Galli, Dvorak, Dvorak and Cantor, 1981; 
Razin, Cordon-Cardo and Good, 1981; Tertian, Yung, Guy-Grand and 
Moore, 1981) and is also present spontaneously in the supernatant of 
the mouse WEHI-3 tumour (Nagao, Yokova and Aaronson, 1981; Yung, Eger, 
Tertian and Moore, 1981). It has been variously called IL-3 by Ihle, 
Rebar, Kellar, Lee and Hapel (1982), burst-promoting activity by 
Iscove, Roitsch, Williams and Guilbert (1982), P-cell stimulating 
factor by Schrader and Clark-Lewis (1982) and WEHI-3 factor by Bazill, 
Haynes, Garland and Dexter (1983). This factor has been extensively 
purified and shown to be identical to mast cell growth factor and to 
"histamine-producing cell stimulating factor" (Ihle, Keller, Qroszlan, 
Henderson, Copeland, Fitch, Prystowsky, Goldwasser, Schrader, 
Palyszynski, Dy and Lebel, 1983). The cDNA for the murine IL-3 gene 
has recently been cloned (Fung, Hapel, Ymer, Cohen, Johnston, Campbell 
and Young, 1984; Yokota, Lee, Rennick, Hall, Arai, Masmann, Nabel, 
Cantor and Arai, 1984) thus providing a source of pure IL-3 for the 
analysis of control of haemopoiesis and of the various lineages 
derived from haemopoietic tissues.
IL-3 has an amino acid sequence of 166 residues which includes a 
signal peptide at the N-terminal sequence, and has four potential N- 
glycosylation sites. The generation of the mature form of IL-3 
involves a proteolytic processing step as well as removal of the 
signal peptide (Fung et al, 1984; Yokota et al, 1984). Kinnaird and 
Garland (1985) stated that the action of IL-3 appears to be the 
stimulation of anaerobic glycolysis. Using two IL-3 dependent cell 
lines, AC-2 and Ea-3, they investigated the possible existence of
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different membrane epitopes on each cell line with which IL-3 
interacts. Specific antibodies were raised against the IL-3 dependent 
cell lines and it was concluded that each line may express different 
receptor domains for IL-3 which are stimulated by specific antibody 
binding. However, the possibility that these putative antibodies may 
stimulate through mechanisms unrelated to an "IL-3 receptor" 
interaction is still under investigation.
Mast cells with the morphological features of CTMC have also been 
grown in culture for short periods. Precursors found in rat 
peritoneal washings are stimulated to proliferate by medium 
conditioned by an L-cell fibroblast line. These mast cells stain 
positively with safranin and, when stimulated with compound 48/80, 
release histamine, both are characteristic of CTMC (Czarnetzki, 
Hannich and Niedorf, 1979).
Rats infected with Nix form the basis and source of cellular 
material for the experiments in cell culture carried out in this 
laboratory. Conditioned media capable of causing the proliferation of 
mast cells from normal rat bone marrow cultures were derived from 
cultures of antigen-stimulated MLN cells of rats infected with Nb. 
(Haig, McKee, Jarrett, Woodbury and Miller, 1982). The lymph nodes 
were removed 12-30 days after infection and incubated in culture with 
Nb. antigen. The resultant supernatants were then added to cultures 
containing normal rat bone marrow cells and the resultant total and 
differential cell counts analysed. The cells generated under these 
circumstances had the appearance and staining properties of MMC. More 
convincingly they both contained and secreted the specific protease 
RMCPII. A modified method of this culture routine is utilized to
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investigate the factors involved in this model system and to provide 
sufficient numbers of MMC for investigation. The results obtained are 
documented in this thesis.
It has recently been shown that the rat basophilic leukaemia cell 
line, a chemically-generated tumour cell line maintained in culture, 
is homologous to the rat MMC in that it has similar staining 
properties but, more convincingly, contains RMCPII (Seldin, Adelmen, 
Austen, Stevens, Hein, Caulfield and Woodbury, 1985).
Attempts to culture human mast cells from various haemopoietic 
sources, including bone marrow (Tadakoro, Stadler and De Week, 1983), 
cord blood (Ogawa, Nakahata, Leary, Sterk, Ishizaka and Ishizaka,
1983) and peripheral blood cells (Czarnetzki, Fidger, Kolde, Vroom, 
Aalberse and de Vries, 1984) have been reported. A plethora of 
conditioned media derived from concanavalin A or phytohaemagglutinin- 
stimulated peripheral lymphocytes (Tadakoro et al, 1983), or bladder 
cell carcinoma cell line supernatants (Rimmer and Horton, 1984) were 
used in an attempt to find a mast cell growth factor source. Despite 
the variety of culture techniques, no definitive liquid mast cell 
culture has been achieved. This has been due mainly to the inability 
to distinguish human basophils from mast cells in vitro. Rimmer, 
Turberville and Horton (1984) have produced mouse monoclonal 
antibodies directed against the granule components of mast cells. 
They are strongly reactive with human mast cells in both connective 
tissue and mucosal sites but not with any other infiltrating leucocyte 
or connective tissue cell type, which is a step in the right 
direction.
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Origin and differentiation of mast cells in vivo and in vitro
One of the most studied aspects of mast cells concerns their 
origin and turnover in adult life. The possibility that the
i
metachromatic granules, one of the visual characteristics of mast 
cells, need not be present in mast cell precursors makes the problem 
of mast cell origin very difficult, disagreement being compounded by 
the heterogeneity of the mast cell population. A detailed light and 
electron microscopic study of MMC differentiation was carried out in 
the rat by Miller (1971). MMC are virtually absent from rat jejunal 
mucosa 8 days after infection with Nb. but they reappeared oh the 10th 
day and subsequently peaked on Day 14 (Miller and Jarrett, 1971). 
Initially the MMC contained small numbers of granules but by Day 14 
they were fully granulated and seen to undergo mitosis throughout the 
course of population expansion. The sequences of differentiation and 
maturation beginning with the blast cell and ending with the fully 
granulated mast cell were readily visualised. The use of both light 
and electron microscopy facilitated the identification of mast cells. 
The granules of the mature and maturing MMC having deeply basophilic 
granules whereas other cell types had only faintly stained inclusions. 
The granules eventually filled the cytoplasm at the expense of the 
other cytoplasmic components and this is similar to the pattern of 
maturation for CTMC (Combs, 1966), eosinophils (Wetzel, Horn and 
Spicer, 1967) and basophils (Wetzel, Horn and Spicer, 1967; Terry, 
Bainton and Farquhar, 1969).
Among many theories, there is one which regards the thymus as a 
central source of mast cell precursors (Ginsburg, 1963; Csaba, Surjan, 
Fischer, Kiss and Toro, 1969). An increase in the number of mast
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cells in the thymus was reported to be induced by various experimental 
treatments and thymic lymphocytes observed under such conditions in 
the blood circulation were considered to be the most plausible mast 
cell precursors (Csaba and Hondinka, 1970). However, Viklicky, Sima 
and Pritchard (1973) found it hard to reconcile the abundance of mast 
cells in the connective tissue of the skin and in the lymph nodes of 
athymic mice with the hypothesis that the precursors of these cells 
were of thymic origin. As mentioned previously, the work of Nawa and 
Miller (1979) showed that an increase in the numbers of MMC occurred 
in infected recipients of thoracic duct lymphocytes obtained from 
donor rats which had themselves been infected 10 days previously. 
These TDL were subsequently fractionated and immunoglobulin negative 
cells were the only ones capable of transferring the MMC response. It 
was not clear at this stage, however, if the transferred cells 
differentiated into the MMC or if they produced factor(s) capable of 
inducing proliferation and differentiation of MMC precursors in the 
gut itself.
A population of small lymphocytes has been isolated from the 
intestinal mucosa of mice, rats and rabbits (Rudzik and Bienenstock, 
1974; Guy-Grand, Griscelli and Vassalli, 1978; Mayrhofer and Whately, 
1983; Schrader, Soollay and Battye, 1983) These cells contain a few 
granules with staining properties very much like those of mast cells 
(Guy-Grand, Griscelli and Vassalli, 1978; Mayrhofer, 1980). It has 
been suggested that these granulated intraepithelial lymphocytes might 
represent a transitional form between lymphocytes and MMC (Guy-Grand, 
Griscelli and Vassalli, 1978). This has been refuted by Huntley and 
colleagues (1984) who demonstrated that the MMC-specific protease 
(RMCPII) was present only in the granules of MMC and globule
26
leucocytes but not the intraepithelial lymphocytes found in the gut. 
This study added further support to the view that MMC and GL are of 
common lineage and strongly suggest that the gut intraepithelial 
lymphocytes are unrelated to them.
Kitamura in collaboration with a number of different workers 
designed and executed a series of elegant experiments involving mice 
of the W/Wv and bg/bg genotypes. The W/Wv mice have a severe 
macrocytic anaemia with a decrease in granulocytes and megakaryocytes 
in the bone marrow and are generally regarded as being mast cell-free. 
The giant granules of beige (Chediak-Higashi syndrome) mice are useful 
as a marker for determining the origin of tissue mast cells. In 1977 
Kitamura et al demonstrated that mast cells of the connective tissue 
type could be derived from transplanted bone marrow. Irradiated 
W/Wv mice were recipients of donor bone marrow cells from beige mice. 
Mast cells that appeared, contained giant granules of the beige type.
Mast cell precursors have been shown to be present in the foetal 
liver of mice on day 13 of intrauterine life (Kitamura, Shimada and 
Go, 1979). In irradiated recipients, the differentiation of mast cell 
precursors of foetal liver origin is controlled locally by the same 
mechanism controlling the differentiation of mast cell precursors of 
adult bone marrow origin. Environmental factors are implicated in the 
mechanisms involved, which is probably why it takes so long for the 
donor type mast cells to develop. It was suggested that CTMC 
precursors are of haemopoietic rather than lymphopoietic origin 
(Kitamura, Shimada, Go, Matsuda, Hatanaka and Seki, 1979). Various 
haemopoietic and lymphoid tissues were injected into W/Wv mice and it 
was found that CTMC appeared in recipient mice after bone marrow or
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spleen cell injections, but lymphoid tissues were very poor sources of 
CTMC precursors.
Crowle and Reed (1984) wanted to determine whether MMC derived 
from bone marrow or from thymus. Mast cell-deficient W/Wv and athymic 
mice were given grafts of bone marrow, spleen cells, thymus cells, 
thymus glands, or anti-Thy-1 treated bone marrow or spleen cells. The 
grafts of thymus glands or thymus cells repaired the MMC deficiency of 
athymic but not W/Wv mice, suggesting that MMC precursors are not 
present in the thymus, although a helper or accessory cell may be 
found. Bone marrow, anti-Thy-1 treated bone marrow, or anti-Thy-1 
treated spleen cells repaired the mast cell defects of W/Wv but not 
athymic mice, suggesting bone marrow contains precursors for both CTMC 
and MMC. Whole spleen grafts repaired the defects of both W/Wv and 
athymic mice, thus the spleen contains both the mast cell precursors 
lacking in W/Wv mice and thymus derived factors or cells needed to 
elicit the MMC response lacking in athymic mice.
The precursors of gut MMC were investigated by Guy-Grand, Dy, 
Luffau and Vassalli (1984). They found that the gut mucosal and bone 
marrow cells have the most MMC precursors but that these two 
precursors differ from each other. The bone marrow-derived MMC 
precursors have a striking property of homing into the gut which is 
not related to any T cell activity or antigenic stimulation since the 
high frequency of gut MMC precursor is observed in nude, germ-free and 
newborn mice, as well as in grafts of foetal gut. Unknown factors 
released in situ are probably responsible for the further 
differentiation of gut MMC precursors from bone marrow-derived MMC 
precursors.
With the development of semisolid culture techniques during the
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past two decades, haemopoietic multipotential stem cells and most of 
the haemopoietic progenitor cells can produce differentiated progeny 
in vitro. Much of the information on haemopoiesis has been gained 
from primary bone marrow cultures stimulated by feeder layer or growth 
stimulatory factors from various cellular sources (Dexter and Testa, 
1980). In particular, the soft agar technique for growing colonies of 
bone marrow cells has helped identify many stem cell and progenitor 
cells and the stimuli to which they respond (Pluznik and Sachs, 1965; 
Bradley and Metcalf, 1966). The cells that give rise to the colonies 
are termed colony forming cells. These are progenitor cells i.e. 
precursor cells capable of giving rise to colonies of one or two cell 
types (Johnson and Metcalf, 1977) with mixed colony forming cells 
giving rise to more than two cell types only seen very occasionally 
(Fauser and Messner, 1979). The pluripotent stem cell is analogous to 
the spleen colony forming unit. It is assayed in vivo by its ability 
to form colonies in the spleens of lethally irradiated animals when 
the pluripotent stem cell is transferred as part of a bone marrow 
reconstitution. The colonies formed contained all the haemopoietic 
cell types (Till and McCulloch, 1 961). Haemopoietic stem cells are 
divided into three categories: the stem cell compartment, the
progenitor cell compartment, and the morphologically recognisable 
compartment (Metcalf, 1977). There is proliferation and growth in 
each compartment, with specialisation occurring with progression from 
one compartment to the next, but cells are not able to move from 
mature to immature compartments (i.e. progenitors cannot revert to 
stem cells), or move to one of corresponding maturation in another 
lineage, e.g. from granulocyte/macrophage progenitor to erthyroid 
progenitor.
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Schrader, Lewis, Clark-Lewis and Culvenor (1981) suggested a 
myeloid haemopoietic origin for mast cells growing in suspension 
cultures, by demonstrating that these cells could be generated from 
colonies grown in agar cultures of bone marrow cells. By direct 
cytologic examination of mixed haemopoietic colonies and mast cell 
colonies, it was clearly demonstrated that mast cells are derived from 
multipotential haemopoietic stem cells and share a common origin with 
other haemopoietic cell lineages (Nakahata, Spicer, Cantey and Ogawa, 
1982). Nakahata et al (1982) concluded that the relatively 
differentiated cell recognisable as a mast cell did not have self­
renewal capabilities. This is at variance with Schrader (1981), where 
homogenous populations of cells that were all granulated, showed a 
plating efficiency in agar of up to 10%, the limiting dilution assay 
confirmed this figure (Crapper and Schrader, 1983). Thus, the results 
of these experiments suggest that differentiated cells with many 
characteristics of mast cells do have significant potential for 
division. In vivo transfer of a single peritoneal mast cell injected 
into the skin of W/Wv mice resulted in a cluster of mast cells 
numbering ~ 2,000, this happened at 6% of injection sites. Therefore, 
this indicated that some peritoneal mast cells kept extensive 
proliferative potential even after morphological differentiation 
(Sonoda, Kanayama, Hara, Hayashi, Tadakoro, Yonezawa and Kitamura,
1984).
Recently, a most interesting finding was reported, where murine 
cultured mast cells of WBB6F^, +/+ origin were transferred to mast 
cell deficient mice (WBBF-|-W/Wv ) whereupon they displayed 
characteristics of either the connective tissue types or mucosal 
phenotype depending on anatomical location. Intravenous injection of
\
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representative connective tissue type mast cells into mast cell 
deficient mice gave similar results to those obtained with the 
cultured mast cells: mast cells developing in the peritoneal cavity,
skin, spleen, and glandular stomach muscularis propria of the WBB6F^ - 
W/Wv recipients stained with safranin and berberine sulphate whereas 
mast cells developing in the mucosa of the glandular stomach stained 
only with alcian blue. Thus, histochemically, it seems that both 
peritoneally derived mast cells and cultured mast cells are able to 
acquire characteristics of either CTMC or MMC, supporting the notion 
that the mast cell phenotype may be regulated, at least in part, by 
the tissue microenvironment (Nakano, Sonoda, Hayashi, Yamatodani, 
Kanayama, Yamamura, Asai, Yonezawa, Kitamura and Galli, 1985). It 
should be acknowledged, however, that histochemistry represents an 
indirect approach to identification of the cellular constituents of 
the cells and some direct biochemistry would substantiate the claims. 
As well as this, surface membrane characteristics of recovered cells 
could be compared to those of the cultured and normal peritoneal mast 
cells (Katz, LeBlanc and Russel, 1983; Razin, Ihle, Seldin, Mercia- 
Huerta, Katz, LeBlanc, Hein, Caulfield, Austen and Stevens, 1984).
In this study a number of assays have been employed to look at 
the origin and differentiation of rat MMC in vivo and in vitro in 
normal and helminth infected animals. The main objectives of this 
study were to generate MMC vitro, using normal and infected rats as 
sources of haemopoietic tissue, thus analysing the effect of helminth 
infection on these animals. The mast cells generated under these 
conditions were then characterised using morphological, biochemical 
and histological techniques in order to try and catagorise them as has 
been done for their in vivo counterparts.
Materials and Methods
Animals and maintenance
The two principal strains of rats used in the experiments 
described in this thesis were (LIS x BN)F«j and F344. Colonies of 
inbred Hooded Lister (LIS) and Brown Norway (BN) rats were maintained 
in the Wellcome Laboratories for Experimental Parasitology (WLEP). 
LIS females were bred with BN males, and the resulting (LIS x BN)F<| 
crosses used at between 2 and 4 months of age. The F344 rats were 
originally purchased from OLAC Ltd. (Bicester, Oxon) and were 
subsequently bred from inbred colonies at WLEP. Breeding and 
experimental animals were housed separately, the former receiving 
breeding diet (Oxoid Ltd., Hampshire) and the latter Diet 41 (Hamlyn 
Angus Milling Ltd., Perth). Athymic rats (PVG-mu/mu/Ola) and mu/+ 
heterozygous littermates were purchased from Olac. All animals were 
housed in wire bottomed cages suspended above trays containing wood 
shavings, except when the rats were breeding, when enclosed boxes 
were used. Water and food were supplied ad libitum.
Propagation of N. brasiliensis (Nb.)
Faeces from culture rats infected by the subcutaneous injection 
of 4000 infective Nb. larvae were collected on absorbent paper between 
days 7 and 9 of infection. The faecal pellets were washed under 
running tap water for 2-3 minutes, soaked in sufficient water to cover 
the pellets for 2-3 hours, and were then gently mixed to form a thick 
paste. Granular charcoal (10-18 mesh; BDH Chemicals, Poole, Dorset) 
was added until the mixture was almost dry, but still bound together 
(approximately one volume of faeces to two volumes of charcoal). 
Moist filter paper (Whatman No. 1) was put in the centre of a petri-
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dish, and enough faeces/charcoal mixture was added to cover about 70% 
of the paper. The petri-dishes were stored covered in a moist box in 
a humidified incubator at 27°C for 5-7 days.
The larvae were harvested by gently layering the faeces/charcoal 
mixture on to a piece of filter paper (K-dex, Kleenaroll Ltd., 
London), placed in a fine sieve (300 mesh, Endecott) on a Baermann 
funnel, and larvae collected by sedimentation. Aliquots of the larval 
suspension were counted and the suspension adjusted in saline to give 
4000 larvae per ml.
Infection of experimental rats with N. brasiliensis
Using a 20 gauge 1" needle and 1 ml syringe, 1 ml of the above 
suspension was administered subcutaneously in the groin region of the 
rat. Thus 4000 larvae were the standard infective dose.
Removal of tissues
1. Collection of blood
Animals were anaesthetised in jars containing cotton wool soaked 
in Trichloroethylene (BDH). Blood was obtained by cardiac puncture 
using a 20 gauge needle and 10 ml syringe. Serum was obtained by 
allowing the blood to clot at room temperature. The serum was 
separated from residual blood cells by centrifugation and was stored 
at -30°C prior to use.
2. Excision of lymphoid tissue
Anaesthetised rats were exsanguinated by cardiac puncture and 
killed by cervical dislocation. The rats were placed ventral side up
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on tissue paper. The ventral surface was soaked with 70% ethanol in 
water to prevent any hair or dander from entering surgical openings or 
becoming airborne. The skin was cut from anus to sternum using sharp 
scissors, and peeled back to reveal the abdominal wall. A semi­
circular flap was cut in the muscle and folded back to reveal the 
abdominal contents. Using fine forceps and dissecting scissors, the 
spleen and/or mesenteric lymph nodes were removed as desired. This 
operation was done as quickly and cleanly as possible. All further 
manipulations of the organs were performed in- the microbiological 
safety cabinet (MAT II: Medical Air Technology, Manchester) at room
temperature or on ice.
3. Collection of bone marrow
This was essentially after the method of Spry (1971). Rats were 
anaesthetised, exsanguinated by cardiac puncture, and killed by 
cervical dislocation. The left hind leg of the animal was swabbed in 
70% ethanol and the skin was cut and peeled back to expose the femur. 
This was cut free at the hip joint releasing the entire leg. Holding 
the leg between the fingers and thumbs of both hands, the femur was 
separated from the rest of the leg at the femoro-tibial joint. The 
femur was transferred to the microbiological safety cabinet and all 
subsequent manipulations were carried out in this area. The femur was 
scraped clean of muscle and ligament using a scalpel blade and the hip 
joint end severed near its end using scissors. A 19g needle on a 10 
ml syringe containing Iscove's modified Dulbecco's medium (Gibco, 
Paisley, Scotland) + 20% horse serum (HS) (Flow Laboratories, Irvine, 
Scotland) was inserted through the cartilage at the knee joint end of 
the femur and the plug of marrow expelled into a universal container.
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A single cell suspension was obtained by aspirating gently through the 
19g needle followed by filtration through 2 layers of sterile lens 
tissue (Whatman Ltd, Maidstone, Kent) to remove clumps of cells. The 
cells were sedimentped at 1100 rpm for 7 minutes and resuspended in 10 
ml of Iscove's MDM (Gibco) + 20% HS (Flow Laboratories). For culture 
purposes, strict asepsis along with sterile instruments, containers, 
and media were used throughout.
4. Collection of peritoneal mast cells
10 ml of warm Hanks Balanced Salt Solution (HBSS) (Gibco or 
Northumbria Biologicals Ltd (NBL), Cram ling ton, Tyneside) plus 10% 
HS (Flow Laboratories) were injected into the peritoneal cavity and 
the abdomen gently massaged for about 5 minutes. The peritoneal 
cavity was exposed and the medium rich in peritoneal exudate cells was 
collected using a 10 ml syringe. Cells were washed in medium and 
subsequently used as controls in a number of experiments.
Preparation of media
(
1. General techniques
Glass bottles were sterilized in an autoclave (Denley, 
Billingshurst, Sussex) at 121°C for 15 minutes. Media and other 
labile solutions were sterilised by filtration through 0.22 jam filter 
units (Flow Laboratories; Millipore Ltd, Harrow, Middlesex), with the 
aid of a syringe.
2. Hank's Balanced Salt Solution (HBSS)
Glass bottles containing 87.5 ml distilled/deionised water were 
autoclaved as above. To each was added 10 ml of x 10 HBSS (Gibco or
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NBL). The solution was buffered with 2 ml of 1M Hepes (Gibco or NHL) 
and 0.5 ml of 7.5% sodium bicarbonate solution (Flow Laboratories or 
NBL) to give final concentrations of 20 mM Hepes and 0.35 g/1 sodium 
bicarbonate. This medium was normally supplemented with 10% horse 
serum (Flow Laboratories) or 5% foetal calf serum (NBL) prior to use.
3. Iscove's Modified Dulbecco's Medium
The above medium was obtained as stock solution in 500 ml 
aliquots from Gibco, it contained L-glutamine but no supplements (Cat. 
No. 041-1980). The medium was stored in the dark at -20°C. 10 ml of 
Pen/Strep (Flow Laboratories ) and 50 ul 2-mercaptoethanol (No. 365-5, 
Sigma, Poole, Dorset) were added to each 500 ml bottle.
4. Medium Supplements
Horse serum: Batches of serum were tested for efficacy of
support of growth of bone marrow cells (see liquid bone marrow 
culture). The batch ultimately chosen (Lot No. 29104129) was used 
throughout the entire study except where stated. Aliquots of heat 
inactivated (56°C, 45 mins) serum were stored at -20°C until needed.
Foetal Calf serum (FCS): Lot No. 10401 (NBL) was stored frozen
in 100 ml aliquots. It was heat inactivated and stored as for horse 
serum above.
Pat serum: Pools of (LIS x BN)F-j or F344 rat serum were obtained
from normal animals of either sex. Pools were heat-inactivated and 
sterilised by filtration. Sera were stored at -20°C in 20 ml 
aliquots.
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Iscoves serumless formulation additives
a. Bovine Serum Albumin (No. A-7906, Sigma)
5 g of lyophilised powder was dissolved in 100 ml 
distilled/deionised water, sterilised by filtration and stored at 
4°C until use.
b. Transferrin (Human, No. T2252, Sigma)
100 mg of lyophilised transferrin was dissolved in 4 ml of 
distilled/deionised water and sterilised by filtration. The 
stock 25 mg/ml solution was stable for at least 6 months.
400 mg of soybean lecithin was dispersed in 100 ml of 
sterile acid HBSS (HBSS without Hepes or bicarbonate 
supplemented with 1% BSA and 2 ml Pen/Strep) using an 
ultrasonic water bath at 4°C. The suspension was then 
filtered through 0.45 urn and 0.22 urn filters. Stock 
solutions were stored in sterile universals at 4°C.
Components were added to stock Iscove's medium to the following 
concentrations, with the volume of stock solutions used per 500 ml of 
medium shown in parenthesis:
c, Soybean Lecithin (L- -phosphatidylcholine, No. P-5638,
Sigma)
BSA:
Transferrin:
Soybean Lecithin:
1 mg/ml (10 ml)
25 jag/ml (0.5 ml)
(10 ml)
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Culture Technique
1. General Techniques
Organs were removed from rats aseptically and all further 
manipulations were performed aseptically. Instruments were sterilised 
by soaking in 70% ethanol. All containers and pipettes were either 
sterile plastic disposables (Sterilin, Feltham, Middlesex) or 
sterilised glassware. All manipulations except organ removal from 
rats were performed in the microbiological safety cabinet.
Nucleated Cell Count
0.1 ml of the cell suspension (around 10^ cells/ml) was added to 
0.1 ml of white cell diluting fluid (Turk's solution; 0.01% Gentian 
Violet (BDH Ltd) in 3% acetic acid (BDH Ltd) in distilled water) in a 
small tube and mixed. An aliquot of this was transferred to a 
haemocytometer (Improved Neubauer) and the cells were counted in the 
central large divided area. The number obtained was multiplied by the 
dilution factor (2) and 10^. For a more accurate count a duplicate 
count was made in the opposite chamber of the Neubauer, or all 5 large 
squares in any single chamber were counted and the mean value taken. 
Turk's solution lyses red blood corpuscles, but not nucleated cells, 
the nuclei of which are stained with Gentian Violet.
Viable Cell Count
Exclusion of the stain nigrosin (BDH Ltd) has been the method of 
choice as this dye is non-toxic to cells. The cell suspension was 
adjusted to 2-20 x 10^ cells/ml. A stock solution of nigrosin (1% w/v 
in distilled water, filtered through Whatman No. 1 filter paper) was 
diluted 1:10 in HBSS + 5% FCS just prior to use and 0.1 ml cell 
suspension added to 0.1 ml nigrosin dilution in a small tube. After
38
5-10 minutes, cells were placed in a Neubauer chamber and the number 
of unstained (viable) and black-stained (dead) cells were counted.
2. Culture of Lymphoid Cells
Spleen or lymph nodes were excised as described in Removal of 
Tissues (No.2). A maximum of 3 mesenteric lymph nodes (MLN's) or 
spleens were placed in a sterile universal containing HBSS + 5% PCS or 
HS. MLN's or spleens were then decanted with 10 ml of HBSS into 
sterile plastic stomacher bags and the contents were "stomached" in a 
Col worth Stomacher (Seward Laboratory, Bury St. Edmonds, Suffolk) for 
20 seconds.
The cell suspension, thus obtained, was filtered through 2 
thicknesses of sterile lens tissue into universal containers, was made 
up to 20 ml with HBSS and was sedimented at 150 x g for 7 minutes at 
4°C. The cell pellet was resuspended with HBSS using a Pasteur 
pipette and the washing procedure was repeated until the medium above 
the cell pellet was clear. Following the final wash, cells were 
resuspended in the desired amount of tissue culture medium and 
counted.
3. Preparation of Feeder Cells
Spleens were taken from normal syngeneic rats and irradiated with 
3000 rad from a ^Co source (Dept. Physiology, University of Glasgow 
Veterinary School). The spleens, like the MLNs, were stomached, and 
the cells washed, and plated at 2 x 10^ cells/well in 96-well tissue 
culture plates (Nunc, Paisley, Scotland).
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4. Preparation of MLN Cell Conditioned Medium (CM)
Single cell suspensions of MLN from Nb.-infected rats were 
prepared in HBSS. The cells were counted and resuspended in Iscove's 
serumless medium at 4 x 10 viable nucleated cells per ml. The cells 
were stimulated with 2 pg/ml Concanavalin A (Sigma Ltd or Miles-Yeda, 
Slough). The cell suspension was placed in 120 cm^ tissue culture 
flasks (Nunc) and capped. The flasks were placed in a 37°C incubator 
for 48 hr.
The CM was harvested after sedimenting the cells by 
centrifugation, sterilised by filtration and stored at -20°C.
In one experiment (Section 1, Chapter 3) IMLN cells separated by
the fluorescence-activated cell sorter (FACS IV: Becton Dickinson,
Sunnyvale, CA), were plated at 4 x 10^ cells/well and Con-A added at 2
2
pg/ml in 96-well tissue culture plates (Nunc) to which 2 x 10 
irradiated syngeneic spleen feeder cells/well had been added. The 
cells were incubated for 48 hr in a humidified incubator at 37°C 
flushed with 5% OC^ . The CM were harvested and treated as above.
5. Liquid Bone Marrow Culture
This was modified after the method of Sumner (Sumner, Bradley, 
Hodgson, Cline, Fry and Sutherland, 1972) as described for the culture 
of murine cells. Bone marrow cells were suspended in Iscove's medium 
supplemented with 20% HS at 2.5 x 10~* viable nucleated cells/ml. 1 ml 
aliquots of the cell suspension were added to sterile 24 well tissue 
culture plates (Linbro SpaceSaver, Flow Laboratories) together with
0.25 ml conditioned medium, or 0.25 ml medium as a control. For 
experimental purposes, a pool of three bone marrows was used and set 
up in triplicate. Plates were incubated at 37°C in a humidified
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incubator flushed with 5% 0C>2 in air. Routinely, cells were harvested 
after 4 and 7 days of incubation. Plates were gently shaken to 
suspend settled non-adherent cells. The cells were aspirated 3 times 
using a pasteur pipette and then transferred to small plastic tubes 
(LP3, Luckham Ltd, Burgess Hill, Sussex) and after gentle mixing, 
samples were counted in Neubauer chambers for a total cell count.
To obtain a differential count, cell suspensions in the LP3 tubes 
were centrifuged at 150 x g for 7 minutes. The cell concentration was 
adjusted to within the range 5 x 1 0 ^  - 2 x 10^/ml by removal of the 
appropriate quantity of supemate, the cells were resuspended and 3-5 
drops were added to the cuvettes of the cytocentrifuge (Cytospin 2, 
Shandon Southern Ltd, Runcorn, Cheshire). Following centrifugation at 
600 rpm for 5 minutes, slides were removed and smears allowed to air 
dry before staining with Leishman stain or with one of the mast cell 
specific stains (see Histology).
Cell smears obtained using the cytocentrifuge tended to show an 
increasing cell density from the centre to the periphery of the smear. 
This, coupled, with the fact that mast cells tend to aggregate, meant 
that care had to be taken to select representative areas of the smear 
for a differential count to avoid a bias for or against any particular 
cell type. At least 500 cells were counted moving from the periphery 
of the smear to the centre.
To assay the supernatants from the FACS sorted IMLN cells, a 
further modification of this technique was carried out. A pool of two 
rat bone marrows was used for each assay. The bone marrow cells were 
prepared in Iscove's medium + 20% HS, adjusted to a concentration of 
5 x 10^ cells/ml. 100 jil volumes of cell suspension were distributed 
in 96-well flat-bottomed tissue culture plates (Nunc) to which were
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added 50 jil of CM from FACS-sorted cells and 50 pi of Iscove's medium 
+ 20% HS. Each supernatant was tested in triplicate. The cells were 
incubated at 37°C in a humidified incubator flushed with 5% GC>2/ an^ 
harvested after 7. days, total cell counts were then performed. 
Cytocentrifuge preparations were made and stained as previously 
described.
6. Bulk Cultures of Bone Marrow Cells
5 x 10^ viable nucleated cells/ml in Iscove's medium + 20%
2 2HS + 25% conditioned medium were dispersed into 25 cmA or 120 cm*' 
capped tissue culture flasks (Nunc). These were incubated at 37°C for 
7 days. At this time, the cultures were restimulated with conditioned 
medium and re-fed with fresh Iscove's medium + 20% HS by centrifuging 
the cell suspension and resuspending the cells in the medium. Such 
cultures could be maintained for up to 6 weeks after plating and 
routinely contained >99% mast cells after 3 weeks in culture.
Histology
1. Bone Marrow Cells
Differential Cell Count
2-5 drops of a bone marrow cell suspension of between 5 x 1 0 ^  and 
5 x 10^ cells/ml in buffer or medium which contained a percentage of 
serum were added to cuvettes of a cytospin centrifuge. The cells were 
then spun on to a clean glass slide at 600 rpm for 5 minutes. Smears 
were allowed to air dry for 10 minutes, before staining with Leishman 
stain (Gurr, BDH Ltd). Slides were flooded with Leishman stain and 
left for 5 minutes. An equal volume of buffered water (0.05M
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phosphate buffer, pH 6.8) was added to the slide and staining was 
allowed to proceed for a further 20 minutes. The slides were rinsed 
under tap water, blotted dry, mounted and covered using "DPX" (BDH 
Ltd) mountant. Standard procedure for counting bone marrow has been 
outlined under the paragraph of liquid bone marrow cultures above. A 
x 40 objective was used and a minimum of 500 cells were counted.
Specific Mast Cell Staining
Fixation: Bone marrow cytospin smears were air-dried for 10
minutes and then fixed in Camoy's (6 parts absolute alchohol, 3 parts 
chloroform, 1 part glacial acetic acid) for 10 minutes, 4% 
paraformaldehyde for 30 minutes, or methanol for 10 minutes. The 
slides were then rinsed in water.
Toluidine Blue: Slides were covered with 0.1% solution of
toluidine blue (Gurr, BDH) in 0.5N HC1 (pH 0.5) for 15 minutes then 
rinsed in 0.125N HC1. Smears were mounted as above. Mast cells were 
characterized by the presence of purple, metachromatically-stained 
granules in the cytoplasm.
Astra Blue/Safranin: This technique was after Enerback (1966b).
Smears were stained with 0.1% astra blue (Gurr) in 0.7N HCl (pH 0.3) 
for 30 minutes followed by 10 minutes in 0.7N HCl to aid 
differentiation. 0.1% safranine-0 (Gurr) in 0.125N HCl was added for 
15 minutes as counterstain. Mast cells contained blue-staining or 
orange-red-staining granules depending on proteoglycans present (see 
text).
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2. Immnnoperoxidase Staining of RMCPI and RMCPII
Cytospin preparations of peritoneal wash cells and cultured cells 
were fixed in 4% p araformaldehyde, Carnoy's fluid 
or methanol. The sections were either used fresh or were frozen and 
stored at -20°C until use. Cell smears were rehydrated. Endogenous 
peroxidase activity was inhibited with periodic acid (1% w/v, 10 min) 
and the sections treated with 10% BSA in PBS for 30 minutes before 
being incubated overnight with monospecific rabbit F(ab' ) 2 anti-RMCPI 
or rabbit Ffab'^ anti-RMCPII (8 pg/ml diluted in 2% BSA in PBS) in a 
humid chamber. Development was accomplished using sheep F(ab) anti­
rabbit F(ab,)2 “Peroxi^ase conjugate and peroxidase activity was 
revealed with the substrate 3-amino-9-ethyl-carbazole or 3,3 
diaminobenzidine (Newlands, Huntley and Miller, 1984). Washing 
between steps was with TRIS-HC1 pH 7.4. Positively stained cells were 
coloured red or brown depending on staining technique used (Gibson and 
Miller, 1986).
3. Electron Microscopy
Pelleted cells were fixed overnight at 4°C by resuspending in 3% 
gluteraldehyde (BDH) in cacocylate buffer (pH 7.4). They were then 
rinsed in buffer and post-fixed by resuspending in 1% osmium tetroxide 
for 1 hour. The cells were then rewashed in buffer. The samples were 
dehydrated through an ascending series of alcohols, treated with 
propylene oxide, and embedded in Araldite in standard fashion. 
Semithin sections (1 pm) and ultra thin sections (60-90 nm) were cut 
with a Reichart 301 ultratome. The 1 pm sections were stained with 
toluidine blue and the ultrathin sections mounted on copper grids and 
double stained with uranyl acetate and lead citrate. They were
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examined with a Philips 301 transmission electron microscope. The 
processing of the cells for electron microscopy and operation of the 
microscope was carried out by Dr. Paul McMenamin (Dept, of Anatomy, 
University of Glasgow) to whom I am most grateful.
4. Fluorescent Antibody Labelling of Cells 
Monoclonal and Fluorescent Antibodies
The mouse anti-rat monoclonal antibodies 0X19, W3/25, W3/13, 0X6, 
0X7 and 0X8 were a generous gift of D.W. Mason (MRC Unit for Cellular 
Immunology, Sir William Dunn School of Pathology, University of 
Oxford). Subsequent batches of the above monoclonal antibodies were 
purchased from Seralab (Crawley-Down, Sussex).
Mouse IgG was kindly provided by A. Williamson, Department of 
Biochemistry, University of Glasgow. Fluorescent goat anti-mouse IgG 
was prepared according to the method of Barclay and Hyden (1978). 
Goat anti-mouse IgG was passed through a rat globulin immunosorbent 
column to remove reactivity for rat IgG. The antiserum was then 
purified by immunosorption to mouse IgG, and after elution was 
subsequently digested with pepsin according to Nisonoff, Wissler, 
Lipman and Woernley (1960). The purified Ffab1^  fragments were 
isolated by gel filtration on AcA 44 and conjugated with fluorescein 
isothyocyanate by the method of Barclay and Hyden (1978) to obtain 
fluorescein Ffab1^  molar ratios of between 2 and 4. Batches of this 
antibody were stored at -20°C and each batch was titrated to obtain 
optimum fluorescence before use. Fluorescein conjugated sheep Ffab'^ 
anti-mouse IgG (New England Nuclear, Stevenage, Herts) was also used 
in certain experiments (see text).
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Labelling of IMLN Cells with Monoclonal and FITC labelled antibodies 
A single cell suspension of 10® cells/ml was incubated with 2.5- 
5.0 pl/ml of the monoclonal antibody (0X19, W3/25 or 0X8) i.e. 50-100 
pl/107 of monoclonal cells for 30 minutes at 4°C. After three washes 
in HBSS + 10% normal rat serum (NRS) + 2 mM NaNg, the cells were 
further incubated for 30 minutes at 4°C with FITC-labelled goat anti­
mouse IgG (1:10 or 1:20 dilution, depending on the monoclonal being 
used). The cells were washed again three times in HBSS + 10% NRS + 2 
mM NaNg and maintained on ice prior to sorting on the FACS.
Cell Separation Techniques
1. Removal of Adherent Cells
Plastic adherent cells were removed from mesenteric node
7preparations by incubation in plastic tissue culture flasks. 2 x 10 
cells/ml in Iscove's medium + 10-20% heat inactivated FCS were 
incubated at 37°C in 25 cm^ plastic tissue culture flasks (Nunc) for 2 
hours. Nonadherent cells were removed by gently rocking the flasks 
and decanting the suspension. Adherent cells were cultured in situ if 
desired, by first washing 3 times with warm HBSS + 5% serum and then 
counting 4 x 1  cm* areas of the dish under an inverted microscope 
(Olympus) for an estimate of adherent cell numbers. These cells were 
then incubated in the appropriate volume of Iscove's medium. 
Occasionally, an estimate of phagocytic cells was performed on 
adherent cells using their ability to phagocytose latex particles.
g
0.3 ml of a suspension of latex spheres (0.93 jum diameter, 4 x 10 
spheres/ml, Polyscience Ltd, Warrington, Pennsylvania, U.S.A.) in 
medium + 25% FCS were added to the cells. Cells and particles were
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gently agitated for 1 hour at 37°C. The cells were sedimented and 
washed 3 times in medium or HBSS. Phagocytic cells were identified by 
their content of latex particles either by phase contrast microscopy 
(Leitz Qrthomat) or by ordinary light microscopy on fixed and Leishman 
stained preparations.
2. Removal of Immunoglobulin Bearing Cells
Immununoglobulin bearing cells (Ig+) were depleted by 
immunoadsorption to sheep F(ab' ) 2 anti-rat Ig coupled to CNBr- 
activated Sepharose 6MB (Pharmacia Ltd, Uppsala, Sweden).
Sterile buffers and aseptic technique were used throughout. 1 g 
of gel was swollen in a beaker and washed for 15 minutes on a glass 
filter with 200 ml of a 10“  ^M HCl solution. 4 mg of antibodies 
dissolved in 5 ml of 0.1 M sodium bicarbonate buffer containing 0.5 M 
sodium chloride were added to the gel in a test tube and the mixture 
was rotated end over end for 2 hours at room temperature. After 3 
washes in coupling buffer, the remaining active groups were reacted 
with 0.2 M ethanolamine pH 8.0 for 1 hour. This was followed by 3 
washing cycles to remove non-covalently absorbed protein, each cycle 
consisting of a wash at pH 4.0 (0.1 M acetate buffer containing 0.5 M 
NaCl) followed by a wash at pH 8.0 (0.2 M carbonate/bicarbonate buffer 
containing 0.5 M NaCl). The gel was placed in a sterile 10 ml, 1 cm 
diameter column to a bed volume of 5 ml.
10® adherent cell depleted MLN cells in 1 ml of HBSS + 0.01 % 
sodium azide and 0.3% BSA was added to the column and allowed to 
penetrate the gel. After 15 minutes incubation, unbound cells were 
eluted and collected and the column was washed with 10 volumes of 
HBSS. Bound cells were eluted by the addition of 5 ml normal rat
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gamma globulin. After 15 minutes incubation, the cells were collected 
and the column washed as previously. Bound gamma globulin was removed 
by passing 0.1 M glycine HCl buffer pH 3.0 through the column until no 
more protein could be detected spectrophotometrically in the eluted 
buffer. The column‘was then given 2 cycles of washes using 0.1 M TRIS 
buffer (Sigma Ltd) pH 8.0 and 0.1 M acetate buffer pH 4.0 and finally 
stored at 4°C in the presence of 0.1 M TRIS buffer pH 8.0 + 0.2% 
sodium azide.
3. Fluorescent Identification of Immunoglobulin-Bearing Cells
50 pi of a 2 x 10^/ml cell suspension in HBSS was incubated with 
50 pi of a FITC labelled Ffab1^  preparation of sheep anti-rat Ig 
antibodies (courtesy of Dr. E. Jarrett). After 1 hour at 4°C, the 
cells were washed twice in HBSS and 10 pi placed on to a slide, 
covered, and examined for fluorescence at x 500 on a Leitz Orthomat 
microscope.
4. IMLN Cell Separation on the FACS
The IMLN cells.were prepared and fluorescently labelled as 
previously described. Separation was carried out on a fluorescence 
activated cell sorter (FACS IV: Dept. Zoology, University of
Edinburgh). Labelled lymphocytes were analysed and sorted fractions 
collected on ice in Iscove's serumless medium. Cells were sorted at 
an average rate of 2000-2500 per second. Appropriate forward angle 
light scatter gating excluded dead cells. Under these conditions, the 
average recovery (of viable cells) was 58% and the purity of labelled 
cells 94-97% of total collected. I am most grateful to Andrew 
Sanderson for operating the FACS IV.
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Quantitation of Rat Mast Cell Protease II (RMCPII)
1. Preparation of Extracts
Isolation of RMCPII from the small intestine and the preparation 
of a specific antiserum were as previously described (Woodbury and 
Neurath, 1978). RMCPII was extracted from cultured cells by 
resuspending pellets in 0.15M KC1. The cells were disrupted by 
ultrasonication, freezing and thawing. The debris was removed by 
centrifugation at 1500 x g for 15 minutes.
Serum samples were prepared as described previously. RMCPII 
content of extracted cells or culture supernatants was assayed by an 
enzyme-linked immunosorbent assay (ELISA) of which two methods were 
used (see 2 and 3 below). Both methods were set up by Dr. J. Huntley 
(Moredun Institute, Edinburgh).
2. Competitive Inhibition ELISA
Plastic 96-well microtiter plates (Linbro) were incubated 
overnight at 4°C with 200 ul of RMCPII at 1 pg/ml per well in 
carbonate/bicarbonate buffer (pH 9.6). The plates were washed four 
times with buffer (phosphate-buffered saline/1 % BSA/0.5% Tween 20). 
Dilutions of a standard (range 5-200 ng/ml RMCPII) or of culture 
extracts or supernatants (3-5 dilutions per sample) were incubated 
separately with a 1:3000 dilution of rabbit anti-RMCPII in buffer for 
1 hour at 37°C. The reaction mixtures were transferred to the antigen 
sensitized plates (200 pi/well) and were incubated for 2 hours at 
37°C. The wells were washed three times with buffer before incubation 
for 2 hours with 200 pi of horseradish peroxidase-conjugated sheep 
F(ab' ) 2 anti-rabbit Fab, diluted 1:1100 with buffer. After three 
further washes, wells were incubated for 20-30 minutes with O-
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phenylenediamine dihydrochloride (Sigma Ltd) in phosphate/citrate 
buffer (pH 5.0). The reaction was stopped by adding 50 jil of 12.5% 
sulphuric acid per well. The O.D.^^ r^ad by a Dynatech Microelisa 
plate reader, was plotted against the standard and sample dilutions 
and the concentration of RMCPII in culture extracts was calculated 
from the formula:
(Dilution of standard giving 50% inhibition of positive 
control/Dilution of unknown giving 50% inhibition of positive control) 
x 1
The results were expressed as jug of RMCPII per ml of supernatant.
3. Capture ELISA
Plastic 96-well plates (Costar, NBL) were incubated overnight
carbonate/bicarbonate buffer at 4°C in a humidified box. A stock 
solution of RMCPII was prepared and dilutions of 10-80 ng/ml prepared 
from it in PBS/0.1 % Tween 20/2% FCS. Appropriate dilutions of the 
test samples were also prepared. The plates were washed three times 
in buffer (PBS/0.1 % Tween 20/2% FCS). 150 jil of standard and test 
sample were added to the plate and incubated for 1.5-2 hours at 37°C 
in a humidified box. The plates were again washed three times. 150 
jil of sheep anti-RMCPII conjugated to horseradish peroxidase were 
added at a 1:2000 dilution to the plates and they were further 
incubated for 1.5-2 hours at 37°C in a humidified container. The 
plates were washed five times with the washing buffer as before. The 
substrate was as in (2), the reaction time being 10 minutes. A
with affinity purified sheep anti-RMCPII at 1 in
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standard curve was drawn and the test sample values calculated from 
this curve. Four dilutions were prepared per sample and the mean of 
the four values calculated from the standard curve was expressed in
All RMCPII standard preparations and antibody preparations used 
in (2) and (3) were generous gifts from Drs. Steven Gibson and John 
Huntley (Moredun Institute, Edinburgh) to whom I am most grateful.
Tritiated Thymidine Assay
For the assay of mitogen-stimulated DNA synthetic responses, 
0.2 ml cultures of 4x10** cells were set up in 96 well microculture 
plates (Nunc) and 0.2 jiCi of [%]dThd (2 Ci/mmol; 1 Ci = 3.7 x 1 0 ^  
Bq: Amersham International) was added to each well 24 hr before
harvesting. The cells were harvested with a Titertek cell harvester 
on to glass fibre filter pads and [^H]dThd incorporatipn was 
determined after liquid scintillation spectrometry of the pads in a 
Packard B spectrometer.
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SECTION 1 
Chapter 1_
Generation of mucosal mast cells in vitro
Introduction
In this chapter, the experiments performed which led to the 
culture system adopted to generate mucosal mast cells will be 
described. The development of liquid and soft agar bone marrow 
cultures using CM from Nb.-infected rat MLN cells has been described 
previously (Haig, 1982; Haig et al, 1982). In that system, CM was 
made by antigen stimulation of MLN taken from Nb.-infected rats. The 
potency of the CM to induce growth and differentiation of MMC from rat 
bone marrow depended on the ability of the antigen to stimulate the 
MLN cells to produce the necessary factor(s). Since the production of 
batches of potent antigen was highly variable in that some stimulated 
the MLN cells to produce factors capable of stimulating mast cell 
growth in normal rat bone marrow and some did not, it was decided to 
try and stimulate MLN from normal and infected animals with the T cell 
mitogen concanavalin-A. This is of some importance as mitogen 
stimulated lymphocytes are known to produce a variety of biologically 
active substances similar to those produced by antigen activated 
lymphocytes. In particular, T cells secrete lymphokines with a broad 
spectrum of activity including the ability to stimulate the 
differentiation of other T and B cells and the regulation of 
haemopoiesis (Schrader, Arnold and Clark-Lewis, 1980). Thus it was of 
interest to compare the activity of the various CM on bone marrow 
cells in liquid culture.
The variability of the bone marrow response to those CM and 
culture requirements which might most effectively maximise mast cell 
growth and differentiation was also investigated.
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Experiment ]_
Some difficulty was encountered in preliminary cultures in 
provoking normal MLN (NMLN) and immune MLN (IMLN) to produce a potent 
CM with Con-A. Various doses of the mitogen and various incubation 
periods were tried. Ultimately the best results were obtained with 
NMLN stimulated by 2-10 pg/ml Con-A for three days in culture and IMLN 
stimulated by 2-10 pg/ml Con-A in a two day culture. Three MLN were 
pooled per group from each normal (LIS x BN)F^ and infected 
(LIS X BN)F-j rat and stimulated with the various doses of Con-A, these 
were then harvested after the appropriate time. Standard 1 ml bone 
marrow cultures were stimulated with the various CM added at 25%, 
including a known potent CM from allergen-stimulated IMLN cells as a 
positive control and medium alone (negative control). Cells were 
harvested on days 4 and 7 of culture and the results represent the 
mean of triplicate samples, from a representative experiment. (See 
appendices 1 and 2 for data from repeat experiments).
Results
The CM prepared using NMLN activated by 5 pg/ml Con-A, stimulated 
mastocytopoiesis and total cell growth to almost the same extent as 
the antigen stimulated IMLN cells (positive control) (Figure 1). The 
other CM were not as effective. Figure 2 shows that IMLN cells 
stimulated with 2 pg/ml Con-A gave a total cell and mast cell growth 
which far surpassed the ability of the other CM including the positive 
control to stimulate normal rat bone marrow to grow and differentiate. 
It was therefore apparent that both NMLN and IMLN could be stimulated 
with an appropriate dosage of Con-A to produce mast cell growth factor
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%
of similar or superior potency to that produced by allergen-activated 
immune rat MLN.
Experiment 2
A comparison was made between the stimulatory effect of Con-A on 
normal and immune rat MLN by measuring the level of incorporation of 
tritiated thymidine [^H]dThd. This was done to see if a measure of 
the potency of the CM to stimulate growth of MMC from normal rat bone 
marrow could be predicted. For this assay, MLN were removed from 
(LIS X BN)F-j normal and immune rats (3 per group). The cells were 
cultured in the presence of 2 and 5 pg/ml Con-A. The details for 
assay of mitogen-stimulated DNA synthetic responses can be found in 
the Materials and Methods. The results are expressed as the mean 
counts per minute (cpm) on day 3 in triplicate cultures. Bone marrow 
cultures were harvested on day 7 and cell numbers expressed as the 
mean of triplicate cultures, from a representative experiment. (See 
appendix 3 for data from repeat experiment).
Results
In the experiment shown in Table 1, the effect of Con-A on NMLN 
and IMLN was assessed by measuring incorporation of [%]dThd into the 
MLN cells. The DNA synthetic responses to Con-A stimulation were
f
considerably greater in immune than in normal MLN. However, it was 
evident that the level of incorporation of [ H]dThd could not be taken 
as an indicator of the potency of the CM to induce total and mast cell 
growth in normal bone marrow.
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lOOn Total Cells
80-
60-
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Mast Cells
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12-
4-
Days in culture
• IMLN + nt. allergen o NMLN +■ 2pglml Con-A 
a NMLN+5fjglml Con-A  ^ NMLN +10pglml Con-A 
■ Medium alone
Figure 1: Total cell and mast cell growth in normal bone marrow
cultures stimulated with conditioned media made from NMLN stimulated 
with various concentrations of Con-A
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=  4 0 - i Mast Cells
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16-
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Days in culture
•  IMLN + nt. allergen o IMLN+2jjglml Con-A 
*  IMLN +5|jglml Con-A A IMLN i-IOpglml Con-A
■ Medium alone
Figure 2: Total cell and mast cell growth in normal bone marrow
stimulated with conditioned media made from IMLN stimulated with 
various concentrations of Con-A.
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Table 1_: Total cell and mast cell growth in bone marrow cultures
stimulated with CM from Con-A activated normal or immune 
MLN cells
Source of CM
[3H]dThd 
incorporation 
in MLN cultures 
cpm x 10
Bone Marrow
Total Cells 
no x 10
Cultures
Mast Cells 
no x 10
Normal MLN
+ 2 pg Con-A/ml 11.0 28.0 5.8
+ 5 pg " " 1.0 56.0 16.8
Unstimulated 2.2 3.0 0
Immune MLN
+ 2 pg Con-A/ml 5.5 79.0 40.1
+ 5 pg " 11 72.3 63.0 14.1
Unstimulated 0.4 5.0 0
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Experiment _3
In investigating the growth and differentiation of the mast cells 
which appeared in the cultures, it was of interest to look at the 
CM requirements of these cells; would.initial pulsing of the cells 
with CM give the necessary stimulation for growth and differentiation 
or does CM have to be present throughout the period of culture? One 
ml standard bone marrow cultures were set up with a known potent CM 
added to each well excluding the negative control. After 24 and 48 
hrs in culture, cells were removed from the wells, washed in medium 
and re-plated without CM. Control groups included; cells which were 
washed and then re-plated with CM and the normal positive control 
which did not undergo this treatment. The bone marrow cultures were 
harvested on days 4 and 7 after plating and cell numbers expressed as 
the mean of triplicate cultures from a representative experiment. (See 
appendix 4 for data from repeat experiments).
Results
Clearly CM is required at all times during culture of normal rat 
bone marrow if it is to grow and differentiate to give any appreciable 
total cell and mast cell growth above initial plating values (Figure 
3). Compared to the cells which were left in culture with CM and 
those replated with CM (the washing procedure having no detrimental 
effect on the cells) the total cell and mast cell growth in the two 
pulsed groups was negligible. The results show the mean of triplicate 
cultures harvested on days 4 and 7 after plating.
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Total Cells
6 0 -
4 0 -
20 -
=  20-1 Mast Cells
16-
12-
4 -
4 7
Days in culture
•  CM throughout oWashed+CM *2 4 h r pulsing 
a 48hr pulsing ■ Medium alone
Figure 3^: Total cell and mast cell growth in normal bone marrow
cultures stimulated with CM throughout culture, after 
washing and pulsed for 24 hr and 48 hr.
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Experiment
Having established the culture system using (LIS X BN)F-| rats it 
was of interest to see if other strains of rats were able to produce 
potent CM. CM was made from immune MLN taken from 4 strains of 
rats, F344, CBH, AUG and AO, D1 4 after infection with Nb. The IMLN 
cells were stimulated with 2 pg/ml Con-A and harvested after 24, 48 
and 72 hours. The CM were tested on bone marrow taken from the same 
strain from which the CM had been made and (LIS X BN)F^ marrow as a 
control.
The strain variability of the bone marrow response to a known 
potent CM was also investigated. (LIS x BN)F-j CM was used to 
stimulate the BM taken from the above mentioned strains. The results 
show the mean of triplicate cultures harvested on day 7 after plating. 
(See appendices 5-7 for data from repeated experiments).
Results
Table 2 shows the total and mast cell growth obtained from bone 
marrow stimulated with CM made from IMLN taken from syngeneic strains 
of rats, including the standard (LIS X BN)F-j strain used routinely in 
the laboratory. F344 CM with F344 bone marrow gave, the highest total 
cell growth and mast cell growth. Compared to the other strains, 
(LIS X BN)F-| gave a mediocre total cell count and few mast cells, 
therefore the culture system had not been being used to its full 
potential as far as production of growth factors and mast cells was 
concerned. The results shown are from CM harvested after 48 hrs as 
these had optimal growth stimulatory capacity compared to those 
harvested after 24 or 72 hr (see appendix 5 for this data). The bone
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Table 2: Total cell growth and mast cell growth in normal bone maroow
cultures stimulated with CM made from a syngeneic strain of 
rat
Source of CM Source of BM
TotalCells 
no. x 10
TotalMast Cells 
no. x 10
F344 F344 135 62.3
CBH CBH 84 35.9
AUG AUG 93 27.4
AO AO 62 16.7
(LIS x BN)F1 (LIS x BN)F1 79 22.1
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marrow cultures were plated in triplicate and harvested after 7 days. 
The bone marrow results are the mean of triplicate cultures.
Comparison between CM made from the different strains of rats 
tested on the (LIS X BN)F^  bone marrow is documented in Table 3. The 
highest mast cell growth was obtained in the culture stimulated with 
syngeneic CM i.e. (LIS X BN)F^  CM but F344 CM stimulated the mast cell 
growth to almost the same extent. AUG and CBH gave slightly lower 
numbers of mast cells with AO CM generating less than half the numbers 
of mast cells produced by the (LIS x BN)F-j CM. Obviously it was 
desirable to maximise the total mast cell numbers in the culture, thus 
F344 CM used with F344 bone marrow was adopted to give the best yield.
To look at the variability of the bone marrow response between 
strains, (LIS X BN)F-j CM was used to stimulate bone marrow taken from 
the 4 other strains used. Again F344 bone marrow gave the highest 
total cell count and mast cell growth with (LIS X BN)F-| bone marrow 
also giving a reasonable response (Table 4). The other 3 strains gave 
a much poorer response.
62
Table _3: Total cell and mast cell growth in normal (LIS x BN)F-j bone
marrow cultures stimulated with CM made from allogeneic 
strains of rats
Source of CM Source of BM
Total Cells 
no, x 10
Total Mast Cells 
no. x 10
F344 (LIS x BN)F1 63 20.8
CBH i i 51 14.7
AUG it 92 15.9
AO i i 46 9.7
LIS x BN it 79 22.1
Table 4: Total cell and mast cell qrowth in normal bone marrow 
cultures stimulated with CM made from an allogeneic strain 
of rat
Source of CM Source of BM
Total Cells 
no. x 10
Total Mast Cells 
no. x 10
(LIS x BN)F1 F344 87 29.1
CBH 54 17.3
AUG 60 13.8
AO 40 7.6
(LIS x BN)F1 79 22.1
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Discussion
A variety of experimental protocols have been used to establish 
successful liquid rat bone marrow cultures. Bone marrow cells can be 
stimulated to grow and differentiate in the presence of CM prepared 
with MLN cells from Nb. -infected rats stimulated with various 
concentrations of Con-A. Figures 1 and 2 illustrate that medium from 
such cultures enriches for mast cells. Similarly, in the mouse, mast 
cells developed in haemopoietic tissue cultures stimulated with 
mitogen-activated splenocyte CM (Hasthorpe, 1980; Nabel et al, 1981; 
Razin, Cordon-Cardo and Good, 1981; Schrader et al, 1981; Tertian et 
al, 1981). The best total cell and mast cell growth was achieved in 
the rat system by culturing 4 x 10^/ml IMLN cells taken D14 after 
infection with 2 jig/ml Con-A for 48 hrs. This optimal period of 48 
hrs is similar to the in vitro kinetics reported for murine and human 
IL-2 production (Gillis, Ferry, Orr and Smith, 1978) but different 
from the kinetics of factor production in the antigen-induced response 
(Haig et al, 1982). Maximal levels of mast cell growth stimulatory 
activity was obtained only after 4-6 days in culture in the presence
al, 1982). It seems the use of in vivo activated MLN cells from 
infected rats enlarges the population of cells potentially able to 
produce growth factors capable of causing selective proliferation and 
differentiation of rat bone marrow in vitro. This may be because 
those MLN cells are expressing more receptors for Con-A induced growth 
factors (Larsson and Coutinho, 1979) and hence undergo a more rapid in 
vitro expansion than the resting MLN cells of normal animals. In this 
particular case the MLN greatly increase in size and cellularity
worm secretory-excretory product (Haig et
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during infection. The MLN has proven to be the most potent source of 
mast cell growth stimulatory activity compared to the other tissues 
evaluated (spleen and peripheral blood), indicating that this is a 
major source of activated lymphocytes during Nix infection (Haig, 
Jarrett and Tas, 1984). In time course experiments it was found that 
mast cell growth stimulatory activity could be detected in CM from day 
10 of infection with Nh onwards, reaching maximal levels at around 
day 14 and persisting for at least 30 days (Haig, Jarrett and Tas, 
1984). This coincides with the kinetics of appearance in vivo of MMC 
in the lamina propria of infected rats (Jarrett, Jarrett, Miller and 
Urquhart, 1967; Nawa and Miller, 1979; Denburg, Befus and Bienenstock, 
1980; Haig, 1982). Investigations to identify the cells responsible 
for the production of the factor(s) causing growth and differentiation 
of mast cells from normal bone marrow will be described in subsequent 
chapters.
There are various parameters which can affect the potency of CM 
in stimulating the growth and differentiation of mast cells from 
normal rat bone marrow. It is evident from Experiment 4 that I MLN 
cells taken from different strains have a varying capacity to be 
stimulated by Con-A to produce the necessary factor(s) for mast cell 
growth. (LIS X BN)F<j rats had been chosen initially because they were 
readily available, were good breeders and were able to tolerate 
helminth infection well. However, MLN cells from F344 rats secreted a 
very potent CM and have subsequently proved to be consistently better 
than MLN cells from other strains. Therefore, F344 rats are the 
strain of choice for CM production. There is obviously still some 
variation between batches of CM but this can be minimised by excising 
the nodes on the same day after infection, stimulating with the same
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brand of Con-A and by preparing the components of the serumless medium 
according to the strict protocol detailed in the Materials and
Methods. The pr e p a r a t i o n  of the soybean lecithin
(phosphatidylcholine) in particular seems to be of crucial importance 
and any deviation in quality or preparation of this component affects 
the potency of the CM. It should also be noted that for any 
particular experiment, one batch of CM should be used throughout and 
this has been done in the experiments included in this thesis.
The varying response of the different rat strains to Nb. 
infection as far as worm burden and mast cell response in the
intestine was investigated by Nawa and Miller (1979). Both the worm
burden kinetics and mast cell responses were different in each strain 
of rat used. In addition they found that the intestinal mast cell 
response could be transferred using thoracic duct lymphocytes (TDL) 
which were slg- and that the increase in intestinal mast cell numbers 
was closely related to the final stage of the rapid phase of worm 
expulsion. It was also noted that the timing of transfer of the TDL 
after infection was also important, day 10 TDL being the most 
effective in conferring the response. These in vivo phenomena appear 
to be being mirrored in the in vitro culture system where the ability 
to stimulate mast cells in normal bone marrow cultures is dependent 
upon the strain of rat used to make the CM and also the time after 
infection when the nodes are removed.
Reactivity to a given CM by different bone marrow pools was 
slightly variable from one pool to another. This had previously been 
observed by Bradley and Siemienowicz (1968). Therefore it was not 
considered valid for experimental results to be expressed as the mean
66
of values from repeated experiments using different bone marrow pools. 
Representative experiments are presented, supported by results from 
repeated experiments, using both different bone marrow pools and 
different batches of CM. This cross checking procedure was followed 
for all the experiments contained in this thesis. The results of 
repeated experiments are tabulated in the appendix.
In studying the variability of bone marrow to respond to a given 
CM, F344 rats gave consistently higher mast cell numbers than the 
other strains. It should be noted that on this occasion the bone 
marrow responded better to CM made from syngeneic than from allogeneic 
I MLN cells. Results in Table 2 and Table 4 confirm this although it 
must be said that in general, this is not always the case because so 
many factors may affect the potency of CM that many more detailed 
experiments would be necessary to determine the involvement of 
histocompatibility barriers in the action of CM on mast cell growth.
Again it is interesting to compare these findings to the results 
obtained in vivo. It was shown that although reciprocal adoptive 
transfers of IMLN cells between rapid (NIH) and slow (BIO.G) responder 
strains of mice to the nematode Trichinella spiralis, could enhance 
the mast cell response in normal recipients and partially restore the 
response in sub-lethally irradiated recipients, the magnitude of the 
response in each case was determined primarily by the phenotype of the 
recipient (Wakelin and Donachie, 1980). As well as this, studies 
using chimaeric mice show clearly that bone marrow cell phenotype 
plays a major role in determining the level of response to infection 
whether or not IMLN cells are transferred (Alizadeh and Wakelin, 
1982). The in vitro system established in this laboratory provides an 
opportunity to further investigate the mechanisms at play in the rat
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and compare it to the findings in the mouse.
The main objective of the experiments in this chapter was to find 
the optimum conditions for culture of maximum numbers of mast cells in 
vitro. There was a number of interesting and puzzling trends which 
became apparent and, given time, could be followed up.
Eosinophils, monocytes/macrophages and neutrophils (but not 
lymphoid or erythroid cells) are also stimulated by CM in bone marrow 
cultures but these cells disappear during the first 10 days of culture 
(Haig, 1982). There are no progressive stages of mast cell 
development in unstimulated rat bone marrow but in stimulated 
cultures, cells with sparse granulation can be seen by day 2 and these 
progress by the end of the first week to form cells which satisfy the 
usually accepted criteria of mast cells i.e. metachromatic granular 
dye-binding when stained with toluidine blue, ultrastructural 
appearance and uptake of IgE (Galli and Dvorak, 1979; Haig et al,
1982). However cultured mast cells differed morphologically from any 
cell seen in normal uncultured marrow. When stained with toluidine 
blue or Leishman, the sparsely granulated, red-purple staining mast 
cells bore little resemblance to the occasional densely granulated, 
blue-black staining cells seen in uncultured marrow. This suggests 
that the precursors of the cultured mast cells are very different from 
their progeny. No reliable histological technique at present can 
identify mast cell precursors which are, however, thought to resemble 
lymphoblasts (Miller, 1971). Thus for the purpose of this thesis, the 
number of mature CTMC found in bone marrow represent the day O value 
for the cultured cells, even though these cells may not be related to 
the cells ultimately growing in culture, and they die off within 7
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days of culture.
The experimental results represented in Table 3 shows that the 
mast cells require the presence of CM continually in the culture in 
order to grow and differentiate. Restimulation and refeeding leads to 
cultures containing almost 100% mast cells by 2-3 weeks after plating. 
Bulk cultures of these mast cells may henceforth be maintained for at 
least 8 weeks in the presence of CM. The characteristics and 
properties of these cultured mast cells will be described in Section 
2.
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Chapter 2
Stimulation of MMC growth in normal and nude rat bone marrow cultures
Introduction
In both rats and mice, the MMC response to helminth infection is 
immunologically mediated. It is dependent on the integrity of the T- 
lymphocyte system of the host (Ruitenberg and Elgersma, 1976; 
Mayrhofer, 1979) and can be accelerated in infected animals by the 
adoptive transfer of immune lymphocytes (Befus and Bienenstock, 1979) 
or immune T cells (Nawa and Miller, 1979). It was speculated that the 
T cells in this response could be acting in two ways: they might
develop into mast cells as hypothesised by Burnet (1977), and 
seemingly supported by growth of mast cells from thymus cell cultures, 
or they may produce a lymphokine which induces proliferation and 
development of MMC precursors.
The experiments described in this chapter were performed to 
explore the basis of the thymus dependency of MMC proliferation.
Experiment _5
Cell fractionation experiments were undertaken to examine which 
population within the MLN was producing the factor(s) responsible for 
the selective growth and differentiation of MMC in normal bone marrow 
cultures. Phagocytic cells were removed from immune MLN cells, taken 
day 14 after infection, by adherence to plastic?and the remaining 
cells were fractionated on a sheep Ffab'^ anti-rat Ig-Sepharose 6MB 
column. CM were prepared from unfractionated cells and from each of 
the fractions by stimulating the cells with 2 pg/ml Con-A. The CM 
were then used to stimulate normal bone marrow cultures. The cell 
counts represent the mean numbers in triplicate cultures on day 7.
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Results
Maximal cell growth, including MMC growth, was seen in bone 
marrow cultures stimulated with CM prepared from the T cell-enriched 
fraction of immune MLN (Table 5). Adherent cell-depleted MLN and the 
Ig” fraction contained <1% phagocytic cells, as identified by their 
capacity to ingest 1 pm latex spheres (see Materials and Methods). 
The CM produced by the IMLN depleted of adherent cells had a greater 
mast cell stimulatory capacity than unfractionated IMLN. CM prepared 
from the adherent cell or Ig+ cell fractions did not stimulate bone 
marrow growth (Table 5). These results are from a representative 
experiment. (See appendix 8 for results from repeated experiments).
Experiment 6^
To explore the nature of the T cell dependance of mast cell 
growth stimulatory activity, as indicated in the last experiment, we 
tested the stimulatory capacity of the CM prepared with athymic rat 
lymphocytes and the ability of the athymic rat bone marrow to generate 
MMC. Thus, CM were prepared from m u / m u  and mu/+ MUSI 14 days after 
infection with 2,000 Nb. larvae, using 2 pg/ml Con-A to stimulate the 
cells in culture. These CM were tested on rnu/rnu and rnu/+ bone 
marrow in standard culture. A CM from Nb.-infected (LIS x BN)F-j rat 
MLN was used as a positive control. Different batches of CM were 
tested against different bone marrow samples in separate experiments. 
The bone marrow cells were harvested on days 4, 6, 8 and 10 of culture 
and the results represent the mean of triplicate cultures from a 
representative experiment. (See appendix 9 for additional data).
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Results
(LIS x BN)F-j CM contained the most potent activity for total bone 
marrow and mast cell growth in both rnu/rnu and rnu/+ BM cultures 
(Figure 4). CM from rnu/+ rats stimulated total cell and mast cell 
growth in both m u / m u  and mu/+ bone marrow cultures whereas CM from 
m u / m u  animals contained no growth stimulatory activity. It is also 
observed that both (LIS x BN)F-j CM and rnu/+ CM can stimulate mast 
cell growth in rnu/rnu bone marrow cultures to the same extent as 
mu/+ bone marrow.
Experiment ]_
In order to verify that the mast cells growing in cultures from 
rnu/rnu bone marrow were of a similar type to those grown from 
(LIS x BN)F-| marrow i.e. mucosal type, athymic and intact rat bone 
marrow cells were cultured in the presence of CM from immune MLN 
stimulated with 2 pg/ml Con-A. Cultures were harvested on the days 
shown for total and differential cell counts. The measurement of 
RMCPII (the MMC marker) in the culture supernatant was performed by an 
enzyme-linked immunosorbent assay (as detailed in Materials and 
Methods). Comparison between the two bone marrow types was assessed 
by these criteria. (See appendix 10 for additional data).
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TABLE 5: Total cell and mast cell growth in bone marrow cultures
stimulated with fractionated immune MLN cells.
Source of CM
Total Cells 
no. x 10
Mast Cells 
no. x 10
Unfractionated immune MLN cells 59.0 25.9
Immune MLN without adherent cells 94.9 45.7
Adherent cells alone 8.0 0.6
Ig+. cells 6.5 0.2
Ig“ cells 106.5 66.1
Medium alone 7.5 0.1
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Figure 4: Total cell and mast cell growth in rnu/rnu and rnu/ + rat
bone marrow cultures stimulated by various CM
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Results
Concentrations of RMCPII in supernatants from both (LIS x BN)F-j 
and rnu/rnu mast cell cultures were comparable (Table 6). 
Additionally, the mast cells of m u / m u  origin had identical staining 
characteristics to those of (LIS x BN)F-j origin; both populations 
stained with astra blue in preference to safranin at pH 0.3 after 
Camoy's fixation.
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Discussion
It has previously been shown that mast cells with the 
characteristics of MMC appear and proliferate to form the predominant 
cell type in rat bone marrow cultures stimulated with factors from 
antigen reactive IMLN (Haig et al, 1982) and, in the present study, 
with Con-A stimulated normal or immune MLN (Haig et al, 1983).
The factor was produced uniquely by immunoglobulin-negative non­
adherent lymphocyte-enriched preparations and . not by adherent or 
immunoglobulin-positive cell-enriched fractions (Table 5). It should 
be noted that the adherent cells seem to have a suppressive effect on 
factor production for when they were removed, CM from non-adherent MLN 
preparations generated higher total cell and mast cell growth. Since 
the Ig“ adherent cell-depleted fraction was contaminated by only small 
numbers of adherent cells (~1%) this yielded the best total cell and 
mast cell growth. T cells as the source of mast cell growth factor 
was confirmed in the experiments with rnu/rnu and rnu/+ rats where 
supernatants from MLN cell cultures from rnu/rnu rats failed to 
generate mast cells in bone marrow cultures, whereas CM from rnu/+ 
rats did contain mast cell growth stimulatory activity. Differences 
in the capacity to produce mast cells between the control (LIS x BN)F^ 
rat IMLN CM and rnu/+ CM may be a consequence either of strain 
differences or of the reduced antigenic priming of the rnu/rnu and 
rnu/+ rats. Thus (LIS x BN)F^ rats used for CM production were 
infected with 4,000 Nb. larvae whereas rnu/rnu or rnu/+ rats were 
given 2,000 larvae in order not to compromise their health.
The extensive in vivo studies of the striking hyperplasia of mast 
cells which occurs during helminth infection have shown that this
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hyperplasia does not occur in T cell-deficient animals i.e. nude mice 
(Ruitenberg and Elgersma, 1976) or T cell-deficient rats (Mayrhofer, 
1979), More importantly, this present study agrees with the in vivo 
results of Nawa and Miller (1979) who transferred fractionated TDL 
from Nb. infected rats and found that the intestinal mast cell 
response could only be conferred by cells lacking surface 
immunoglobulin.
One of the questions at issue is whether MMC are derived from a 
T cell precursor (Burnet, 1977) or whether T cells induce growth and 
differentiation from a thymus-independent precursor. The results in 
this chapter have now shown that the numbers of MMC generated in 
rnu/rnu rat bone marrow cultures by factors derived from the 
lymphocytes of intact rats is of the same order as the numbers arising 
in rnu/+ or (LIS x BN)F^ bone marrow cultures. In the experiment 
reported here, the presence of MMC precursors in nude rat bone marrow 
indicates that the normal cycling and production of the precursor is 
not under thymic control, whereas proliferation and differentiation in 
culture is. In vivo, nude mice and normal mice contain similar 
numbers of intestinal MMC when examined under optimal fixation and 
staining conditions indicating that the presence of MMC under 
physiological conditions is not thymus-dependent but that 
proliferation in response to parasite infection is under thymic 
control (Ruitenberg and Elgersma, 1976).
The results expressed in this chapter agree with studies of 
cultured mouse mast cells which have shown that mast cell growth 
factor is produced by activated T cells (Hasthorpe, 1980; Nabel et al, 
1981; Nagao, Yokova and Aaronson, 1981; Razin et al, 1981; Schrader et 
al, 1981; Tertian et al, 1981; Yung et al, 1981). Murine mast cells
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can be maintained in proliferation for prolonged periods in the 
presence of the appropriate factor(s). The factor(s) are associated 
with a lymphokine IL-3 which has been shown to be an absolute 
requirement for the growth of a number of haemopoietic cell lines as 
well as a promoter of the cycling of multipotential stem cells (Ihle 
et al, 1982; Iscove et al, 1982; Schrader and Clark-Lewis, 1982; 
Bazill et al, 1983). It may also be associated with the novel murine 
mast cell and T cell growth factor (TCGF) identified and partially 
purified from the supernatants of the activated helper T cell line 
Cl.Ly1 +2“/9 (Smith and Rennick, 1986). This factor has been shown to 
enhance the IL-3 dependant growth of mast cells and demonstrates that 
an interaction between factors may be required for optimal mast cell 
growth. Cl.Ly1+2“/9 cells also produce high levels of B cell 
stimulating activity. Further studies using cDNA clones that encode a 
lymphokine with all these activities have been carried out and it has 
been proposed the factor be designated IL-4 (Lee, Yokota, Otsuka, 
Meyerson, Villaret, Coffman, Mosmann, Rennick, Roehm, Smith, Zlotnik 
and Arai, 1986).
The presence of RMCPII in supernatants from the rnu/rnu bone 
marrow cultures demonstrates that these cells are of the mucosal type. 
The cells are morphologically identical to and had the same staining 
characteristics as the MMC growing in mu/+ and (LIS x BN)F^ cultures. 
The rat and mouse mast cells described above have several features in 
common. In addition to showing a T-cell dependent hyperplasia the 
mouse bone marrow-derived mast cell is astra blue positive and can be 
grown from nude or T cell depleted bone marrow (Schrader et al, 1981; 
Tertian et al_, 1981). The rat MMC contains non-heparin
glycosaminoglycan and RMCPII (Tas and Bemdsen, 1977; Woodbury et al, 
1978) in distinction to CTMC and, similarly, the cultured mouse mast 
cells synthesize a non-heparin proteoglycan, identified as chondroitin 
sulphate E. In the absence of a specific marker for mouse MMC, these 
criteria suggest the cultured mouse mast cells are of the mucosal 
subtype.
Thus the regulation of a MMC response can be studied in detail 
and in later chapters the phenotype of the T cell producing the mast 
cell growth factor as well as the nature of the mast cells themselves 
will be further characterised.
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Chapter 3_
Surface phenotype of T cells producing growth of mucosal mast cells in
normal bone marrow culture
Introduction
Mast cells emerge and selectively proliferate in normal bone 
marrow cultures under the influence of factors from antigen or Con-A 
stimulated MLN cells from Nbr-infected rats (Haig et al, 1982, Chapter 
1). Cell fractionation studies showed that factor(s) were derived 
from cells lacking surface immunoglobulin and, the use of tissues from 
athymic rats demonstrated that the thymus-dependency of MMC 
proliferation is based on the production of an appropriate growth 
factor by the Con-A activated T cells (Haig et al, 1983; Chapter 2).
In order to further define the source of MMC growth factor, the 
surface phenotype of the cell(s) which produced it was investigated. 
Studies in the mouse showed that T cells which selectively induce 
morphologically normal mouse mast cell clones to proliferate have the 
phenotype Ly1 +2“3“ (Nabel et al, 1981). As mentioned previously mouse 
mast cells generated in culture have some of the features of rat MMC 
and may be of a similar type (Chapter 2).
In the rat, monoclonal antibodies which recognize T cell 
associated antigens include 0X19 which labels all T cells (Dallman, 
Mason and Webb, 1982)* W3/25 (Williams, Galfre and Milstein, 1977) and 
0X8 (Brideau, Carter, McMaster, Mason and Williams, 1980) which label 
non-overlapping T cell subpopulations. Rat helper and 
cytotoxic/suppressor T cell subsets are distinguished by the 
monoclonals W3/25 and 0X8 respectively.
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Experiment J3
IMLN cells removed day 14 after infection with Nb. were separated 
in the fluorescence-activated cell sorter into populations with or 
without the antigens defined by 0X19., W3/25 and 0X8 monoclonal 
antibodies. The selected subpopulations were then cultured in vitro 
with Con-A and irradiated spleen feeder cells (as detailed in 
Materials and Methods). The supernatants were tested for their 
ability to induce MMC growth in a micro liquid bone marrow assay. All 
supernatants were tested in triplicate and the cultures were harvested 
after 7 days. The results are expressed as the mean of triplicate 
cultures. (See appendix 11 for repeated experiment).
Results 
0X19 labelling
Table 7a shows that cells which label with the monoclonal 
antibody 0X19 are capable of producing MMC growth factor, whereas 
those which are negative for this marker are not. Maximal cell 
growth, including MMC growth, was seen in the bone marrow cultures 
stimulated with the conditioned medium prepared from the 0X19 positive 
cells (i.e. the T cell enriched fraction). The CM prepared from the 
0X19 negative cells did not stimulate the bone marrow above the level 
of the medium-alone control.
W3/25 labelling
Cells which stained positively for this monoclonal antibody also 
produced a factor capable of stimulating MMC growth in rat bone marrow 
cultures. Table 7b shows that supernatants from W3/25 positive cells
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TABLE 7a: Total cell and mast cell growth in bone marrow cultures
stimulated with conditioned media from 0X19-labelled IMLN
Source of CM
Total cells 
(x 10 )
Mast cells 
(x 10“4)
Unfractionated IMLN cells 48 26.8
0X19-positive IMLN cells 70 42.8
0X19-negative IMLN cells 8 0.8
Medium alone 4 0.4
TABLE 7b: Total cells and mast cell growth in bone marrow cultures 
stimulated with conditioned media from W3/25-labelled IMLN
Source of CM
Total cells 
(x 10”4)
Mast cells 
(x 10"4)
Unfractionated IMLN cells 56 23.5
W3/25-positive IMLN cells 52 21.8
W3/25-negative IMLN cells 8 0.7
Medium alone 3 0.1
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and unfractionated MLN cells generated comparable numbers of MMC.
0X8 labelling
Table 7c demonstrates that the factor is not produced by cells 
which stain positively for the monoclonal antibody 0X8, the marker for 
the T cytotoxic/suppressor cell. Cells which were negative for this 
marker produced the factor that induced MMC in normal bone marrow 
cultures.
Supernatants from the appropriate control cultures which included 
various combinations of labelled and unlabelled cells _+ feeder cells, 
_+ Con-A and medium alone did not cause any significant MMC growth in 
normal rat bone marrow. Only those cultures which contained FACS 
sorted MLN cells (either labelled or unlabelled depending on the 
monoclonal used) with feeder cells and stimulated by Con-A, produced 
MMC growth stimulatory activity.
Discussion
The experiments described here analysed the phenotype of the T 
cells which produce a factor able to stimulate MMC growth in normal 
rat bone marrow cultures. The results demonstrate that the cells 
express antigens defined by 0X19 and W3/25 but not by the 0X8 
monoclonal antibodies.
The positive control comprising CM from unfractionated MLN cells 
generated the expected total cell and mast cell growth in the cultures 
but the CM from the 0X19-positive fraction, which was T cell enriched, 
promoted an even greater total cell count and a larger proportion of 
mast cells. The removal of the macrophages and other non-T cells had 
an enhancing effect on MMC growth factor production and this is in
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TABLE 7c: Total cell and mast cell growth in bone marrow cultures
stimulated with conditioned media from 0X8-labelled IMLN
Source of CM
Total cells 
(x 10“4)
Mast cells 
(x 10"4)
Unfractionated IMLN cells 60 25.2
0X8-positive cells 4 0.1
0X8-negative cells 64 31.4
Medium alone 4 0.4
85
agreement with earlier results (Haig et al, 1983; Chapter 2). 
Unfractionated and W3/25 positive MLN cell supernatants gave 
approximately the same total cell growth and numbers of mast cells, 
although both parameters were less than those obtained from the 
cultures stimulated by the 0X19 positive fraction supernatant. As 
W3/25 also labels macrophages (Barclay, 1981) this again supports the 
earlier observation (Chapter 2) that their inclusion in culture has a 
detrimental effect on MMC growth factor production. IL-2 is a product 
of W3/25-positive cells which reinforces the idea that this subset 
plays the helper/inducer role in the rat (Cantrell, Robins and 
Baldwin, 1982). T-cytotoxic/suppressor cells, which are labelled by 
0X8 monoclonal antibody, did not produce the factor in amounts large 
enough to generate mast cells in normal bone marrow culture. 
Supernatants from the non-label led population was, on the other hand, 
equivalent in potency to the supernatants from unfractionated MLN 
cells. The small increase observed in total cell growth may have been 
caused by the removal of suppressor cells.
As mentioned previously, the factor(s) produced in this culture 
system would seem to be comparable with murine IL-3. The murine WEHI- 
3b cell line which produces IL-3 constitutively has provided the means 
to purify and analyse IL-3 (Ihle, 1984), a lymphokine with numerous 
effects on haemopoietic cell lines. IL-3 is normally a product of 
mitogen- or antigen-stimulated Thy1+, Lyt1+,2“ T cells (Nabel et al, 
1981) which also produce IL-2 (Miller and Stutman, 1983).
On the basis of molecular weight, tissue distribution and 
functions of cells reactive with the monoclonal antibodies, it appears 
that in the rat, man and mouse, the antigens 0X19, Leu1, T1 and Ly1 
are homologous as are, respectively 0X8, Leu2a, T5 and Ly2 antigens
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are similarly so (Mason, Arthur, Dallman, Green, Spickett and Thomas,
1983). The isolation of the rat T cell subset responsible for the 
production of MMC growth factor was the first step in providing a 
source of the factor itself. However, it is now recognised that the 
sequential expression of genes by a subset of T cells, or even by a 
single clone, may alter the expression of immune function, and 
phenotype of the cell as it differentiates. In this way, the cells 
may gain or lose a function in culture with time or in response to 
different environmental signals (Freeman, Clayberger, Dekruyff, 
Rosenblum and Cantor, 1983; Pawelec, Schneider and Wernet, 1983). 
This feature clearly limits the usefulness of cloning T.cells and 
makes the cloning of IL-3 genes necessary instead.
The cDNA for murine IL-3 has now been cloned (Fung, Hapel, Ymer, 
Cohen, Johnson, Campbell and Young, 1984; Yokota, Lee, Rennick, Hall, 
Arai, Masmann, Nabel, Cantor and Arai, 1984) and more recently the IL- 
3 gene itself (Campbell, Ymer, Fung and Young, 1985). The expression 
of IL-3 from IL-3 cDNA clones in eukaryotic cells has provided an 
opportunity to examine the range of biological activities possessed by 
IL-3 without some of the problems associated with the use of purified 
factors from "normal" biological sources (Hapel, Fung, Young, Johnson 
and Metcalf, 1985; Rennick, Lee, Yokota, Arai, Cantor and Nabel, 
1985). The activities exhibited by this material includes all those 
previously attributed to IL-3. As was expected,the rat IL-3 gene has 
now been cloned and sequenced and expressed in non-human primate cells 
(Cohen, Hapel and Young, 1986). This will provide excellent pure 
material to compare activities with the CM generated by the T cell 
subclass 0X19+, W3/25+, 0X8” in this system.
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Chapter £
Effect of dexamethasone on the production of mucosal mast cell growth
factor and the growth and differentiation of MMC in vitro
Introduction
Physiologically, glucocorticoids are both immunosuppressive and 
anti-inflammatory, although the cellular and molecular basis for these 
effects are poorly understood. These drugs suppress histamine release 
(Daeron, Sterk, Hirata and Ishizaka, 1982; Grosman and Jenson, 1984) 
and prevent the generation of secondarily formed mediators from mast 
cells (Danon and Assouline, 1978; Flower and Blackwell, 1979; Heinman 
and Crews, 1984).
Cortisone treatment of rats prior to Nb. infection completely 
suppresses previously acquired resistance to Nb. and the initiation of 
immunity is stopped completely or at a very early stage (Ogilvie, 
1965). In studying the mechanism of expulsion of the parasite, and in 
particular the kinetics of the mast cell response during Nb. 
infections (Jarrett, Jarrett and Urquhart, 1968), it was observed that 
daily administration of cortisone commencing 5 days before infection 
produced a marked reduction in mast cell numbers (Jarrett et al, 
1967). After withdrawal of the steroid, mast cells reappeared and 
the globule leucocyte reaction occurred, whereupon self-cure took 
place. When cortisone was introduced at day 10 after infection, there 
was no hyperplasia of mast cells, in fact mast cell numbers fell until 
the cortisone was withdrawn. The self-cure reaction then followed 6 
days later. Cortisone can also interrupt the expulsion process when 
administered during the self-cure reaction. The mast cell hyperplasia 
again occurred after cortisone withdrawal and the self-cure followed 
some days later (Jarrett et al, 1967). Rats primed by infection with 
Nb. and challenged intravenously with soluble whole worm antigen 
undergo systemic anaphylactic shock (Jarrett and Miller, 1982). The
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major shock organ responding to anaphylaxis’ in this species is the 
small intestine, and associated with the intestinal lesions is the 
release, into the blood and lumen of the gut of the MMC proteinase, 
RMCPII (Miller et al, 1983; King and Miller, 1984). The release of 
RMCPII provides a unique and specific marker of in vivo activation of 
MMC. The concentration of RMCPII in the tissues, intestinal 
secretions and blood was measured to analyse the anti-anaphylactic 
activity of corticosteroids, on the mucosal mast cell subpopulation 
(King, Miller, Newlands and Woodbury, 1985). The manifestations of 
anaphylaxis were abolished in rats treated with corticosteroids 24 and 
48 hr before intravenous challenge with antigen. Suppression of the 
response was associated with depletion of RMCPII and of MMC from the 
intestinal mucosa.
Both the direct effect of corticosteroids on MMC and their effect 
on T cells were of interest because MMC hyperplasia during helminth 
infection is an apparently T cell-dependent event (Mayrhofer, 1979; 
Nawa and Miller, 1979). Furthermore, dexamethasone exerts an 
inhibitory effect on lymphokine production by T lymphocytes in vitro 
(Gillis, Crabtree and Smith, 1979a; 1979b; Kelso and Munck, 1984).
Experiments were designed therefore to investigate the activity 
of dexamethasone in the culture system, using a dual approach: 
firstly to investigate the influence of dexamethasone on the 
production of MMC growth factor (Experiment 9) and secondly, to 
determine its effect on the growth and differentiation of the cultured 
mast cells (Experiment 10).
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Experiments £
IMLN cells taken day 14 after infection with Nb. were plated at 
4 x 10^/ml and stimulated with 2 |ig/ml Con-A as for normal production 
of CM. In addition to this, dexamethasone. was added to the cultures 
at 10“^M, 10“^M and 1 CT®M with and without Con-A. The cultures were 
harvested after 48 hr and the supernatants dialysed against three 
changes of PBS over 48 hrs to remove the dexamethasone. The 
supernatants were then checked for MMC growth stimulatory activity 
using the bone marrow assay. On harvesting, the bone marrow cultures 
were extracted with 0.15M KC1 and the levels of RMCPII were measured 
using the ELISA in order to verify that growth of MMC was being 
stimulated. The results shown are those obtained from a 
representative experiment harvested on day 7 and are the mean of 
triplicate cultures. (See appendix 12 for additional results).
Results
Dexamethasone inhibited the production of both total cell and MMC 
growth stimulatory activity in a dose-dependent fashion (Table 8). 
Total cell growth and mast cell growth in the positive control (IMLN 
14 + 2 jig/ml Con-A) were, respectively 5 and 16 times that of the
o
10~°M dexamethasone + Con-A treated culture. With increasing 
concentration of dexamethasone both total cell and mast cell numbers 
decreased. The RMCPII content of the bone marrow cultures also 
reflected the numbers of mast cells present, with the positive control 
again containing the highest concentration of RMCPII and the level 
decreasing with increasing concentration of dexamethasone.
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TABLE 8: Effect of dexamethasone (Dex) on the production of MMC
growth factor by IMLN cells, stimulated by Con-Af 
and assayed by growth of MMC in normal bone marrow 
cultures.
Conditioned Medium
Total Cells Mast Cells RMCPII content 
x10 /ml x10 /ml pg/ml
IMLN 14 + 10_8M Dex + Cbn-A 12 1.68 0.68
" 10_7M " " 10 0 0.16
« i0 -6m .. •, 0 0-0i
BffiH 14 + 10-8M Dex alone 3 0 0.01
" 10“7M " " 2 0 0.02
" 10_6M " " 1 0 0.02
IMLN 14 + 2 pg/ml Con-A 60 27.0 3.46
Medium alone <1 0 0.01
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Experiment 10
Normal bone marrow cultures were set up according to materials 
and methods. Dexamethasone was added to the cultures at 10“^M, 10~^M
Q
and 10 “°M with and without CM. The cultures were harvested after 7 
days. Total cell counts were performed and differential cell counts 
carried out on Leishman stained cytospin preparations. On harvesting, 
the cells were pelleted by centrifugation and extracted with 0.15M KC1 
for RMCPII analysis. The cell culture supernatants were also analysed 
for RMCPII content. The results presented are the mean of triplicate 
cultures and are from a representative experiment (see appendix 13 for 
repeated experiments).
After 7 days, both dexamethasone treated and untreated cultures 
were washed and replated with fresh medium + CM and cultured for a 
further 7 days, whereupon, they were harvested and cytospin 
preparations made. The slides were stained with Leishman and the 
morphology of the mast cells compared in those cultures previously 
treated with dexamethasone and in untreated cultures.
Three week old normal rat bone marrow cultures which contained
fi 7>90% mast cells were treated with dexamethasone at 10 , 10 and
10"*®M for 24 and 48 hrs. After this time the cells were harvested, 
cytocentrifuge preparations made, and RMCPII analysis carried out on 
cell extracts and supernatants. Triplicate cultures were treated for 
each concentration of dexamethasone and the mean of these individual 
results is presented (repeat experiments are detailed in appendix 14).
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Results
Dexamethasone inhibited the total cell growth in the normal bone 
marrow cultures compared to the positive control (NBM + CM), although 
the proportion of mast cells per culture did not vary significantly 
between the different doses of dexamethasone, or the positive control 
(Table 9). The concentration of RMCPII per cell decreased with 
increasing concentration of dexamethasone. The content of the culture 
supernatants followed a similar pattern.
The mast cells in the dexamethasone-treated cultures differed 
from the positive control culture in that the granules in the drug- 
treated cells were much smaller than those of untreated cells (Figures 
5,6). The mast cells from the treated cultures had the appearance of 
immature cultured mast cells taken from cultures less than 4 days old 
(see Section 2, Chapter 1). Differential cell counts revealed that as 
the concentration of dexamethasone increased, the proportions of 
neutrophils and macrophages became inversely related. Thus the 
percentages of neutrophils and macrophages were approximately equal at
_ o
23% in the presence of 10 M dexamethasone and were, respectively, 36% 
and 9% in 10“^M dexamethasone and 44% and 4% in 10“  ^dexamethasone. 
In the positive control the proportions of neutrophils and macrophages 
were 8 % and 40%. This trend was seen in the repeated experiments.
The dexamethasone-treated cultures which were refed and 
restimulated yielded mast cells which had larger granules, looked more 
mature, and were similar in morphology to the mast cells from the 
untreated cultures (Figures 7,8). The addition of dexamethasone to 
mature mast cell cultures did not cause any change in cell numbers,
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Figures _5: 10 M dexamethasone treated normal bone marrow culture,
harvested on day 7. Note the small granules of the mast cells 
(arrows). Also present are neutrophils (n). Leishman stain (x733).
Figure 61 Normal bone marrow after 7 days in culture in presence of 
CM. The granules of the mast cells are much larger than those in 
Fig.5 (arrows). Note also the presence of macrophages (m). Leishman 
stain (x733).
9 5
_n
Figures 7: Seven day old 10 M dexamethasone treated culture,
washed, refed, restimulated and cultured for a further 7 days. The 
cells are much more heavily granulated, also the granules themselves 
are now much bigger (arrows) than in Fig.5. These cells form >90% of 
culture. Leishman stain (x733)
Figure <8: Seven day old normal bone marrow culture, refed, 
restimulated and cultured for a further 7 days. The mast cells form 
>90% of the culture. Leishman stain (x733).
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in the RMCPII content of the cells or supernatants (Table 10), or in 
mast cell morphology as judged by Leishman staining of cytocentrifuge 
preparations.
Discussion
In addition to exerting anti-inflammatory and immunosuppressive 
effects in vivo, glucocorticoids inhibit and enhance a wide range of 
cell types and functions in vitro by specific receptor-mediated 
mechanisms (Fahey, Guyre and Munck, 1981). Since generation of MMC in 
culture from normal rat bone marrow is a T cell-dependent phenomenon 
(Haig et al, 1983; Chapter 2) and, more specifically, is dependent on 
a factor supplied by helper T cells (McMenamin, Jarrett and Sanderson, 
1985; Chapter 3), it was of interest to determine the effects of 
dexamethasone on the production of the MMC growth factor. It had been 
shown previously that proliferative and cytolytic responses of T 
lymphocytes to antigens and mitogens were profoundly inhibited by 
glucocorticoids (Nowell, 1961; Tormey, Fudenberg and Kamin, 1967; 
Baxter and Harris, 1975). Similarly, Culpepper and Lee (1985) found 
that dexamethasone inhibits the appearance of IL-3 activity in 
supernatants of murine helper T cell clones.
The present results show that MMC growth stimulatory activity is 
greatly reduced in those CM derived from IMLN cultures to which 
dexamethasone has been added. Since it seems that an IL-3 like 
factor (Chapters 2 and 3) is normally generated in these cultures, the 
present results add further support to the data cited above.
The actual mechanism of inhibition of mitogen-induced 
proliferation has been investigated and a number of conflicting
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results obtained. Initially it was shown that glucocorticoids had an 
inhibitory effect on T lymphocytes by a dual mechanism: that is, a 
direct inhibitory effect on T-cell proliferation as well as an 
inhibition of IL-2 production which resulted in the control of clonal 
expansion of activated T-cells (Gillis, Crabtree and Smith, 1979a; 
1979b). Direct inhibition of IL-1 production by macrophages may also 
be important since IL-1 is probably obligatory for inducing and 
promoting the maturation of IL-2-producing cells! inhibition of IL-1 
synthesis could, therefore, be the essential step in glucocorticoid- 
mediated inhibition of T lymphocyte proliferation (Smith, Crabtree, 
Gillis and Munck, 1980; Stosic-Grujicic and Simic, 1982). However 
further experiments revealed two important dissociations. 
Glucocorticoid inhibition of factor secretion was dissociated from 
clonal IL-2 production, because inhibition could be observed even in 
the presence of excess IL-2, and inhibition could be dissociated from 
effects on cell proliferation, because clones were found in which 
factor productionjbut not growth,was inhibited (Kelso and Munck, 
1984). It has also been observed that the generation of factors, 
chemotactic for eosinophils and macrophages from Con-A-stimulated 
lymphocytes, is inhibited by the release of a suppressive factor by 
dexamethasone-treated T lymphocytes and that the latter acts directly 
on the cells producing the chemotactic lymphokines,but not on the 
eosinophil or macrophage chemotactic factors themselves (Hirashima, 
Sakata, Tashiro, Yashimura and Hayashi, 1985).
Investigations at a more molecular level have revealed that 
dexamethasone directly inhibits transcription of the IL-3 gene 
(Culpepper and Lee, 1985). Several pieces of evidence support this: 
the kinetics of dexamethasone action on IL-3 mRNA levels are very
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rapid and consistent with inhibition of transcription, and since no 
detectable precursor or mature IL-3 mRNA accumulated in the nuclei of 
dexamethasone-treated cells, corticosteroid inhibits neither transport 
nor processing of mRNA. These findings demonstrate that dexamethasone 
can inhibit the production of several lymphokines that are produced in 
response to mitogen activation thus modulating the immune response in 
a variety of ways.
Treatment with glucocorticoids in vitro inhibits IgE-dependent 
granule secretion from rat CTMC (Heiman and Crews, 1984), mouse CTMC 
(Daeron et al, 1982) and human basophils (Schleimer, MacGlashan, 
Gillespie and Lichtenstein, 1982) and suppresses the IgE-dependent 
release of preincorporated radiolabelled arachidonic acid and its 
metabolites (Heiman and Crews, 1984). Furthermore, in vivo 
administration of dexamethasone to rats inhibits IgE-dependent release 
of histamine and arachidonic acid when the rat CTMC are subsequently 
labelled and activated in vitro (Marquardt and Wasserman, 1983). 
Preincubation of mouse bone marrow-derived cells cultured in vitro 
with dexamethasone inhibited subsequent IgE antigen-dependent 
exocytosis of secretory granules and the de novo biosynthesis of 
arachidonic acid metabolites (Robin, Seldin, Austen and Lewis, 1985).
The effects of glucocorticoids, both in vitro on the above 
mentioned cells and in vivo on the rat MMC (Introduction), prompted 
the investigation of the effect of dexamethasone on the development of 
the in vitro cultured, bone marrow derived rat mast cell. The neutral 
serine proteinase RMCPII is located uniquely within the granules of 
rat MMC and is present within the cultured mast cells also. 
Dexamethasone treated cells contained less RMCPII than control cells
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as well as secreting less RMCPII into the culture supernatant. The 
granule formation of the treated cells was also affected in that, 
compared to untreated control cells, their granules were much smaller 
and the treated cells looked generally- immature. Removal of 
dexamethasone from the bone marrow cultures permitted maturation of 
the mast cells which were then indistinguishable from those in control 
cultures. These observations extend earlier findings on the ability 
of corticosteroids to suppress the development of intestinal mucosal 
mastocytosis during nematode infection (Jarrett et al, 1967; Olsen and 
Schiller, 1978) by showing that the putative in vitro counterpart of 
rat MMC is also suppressed in its development by corticosteroids.
A novel observation made on the differential cell counts of the 
dexamethasone-treated normal bone marrow cultures revealed that the 
numbers of neutrophils in the cultures increased with increasing 
dexamethasone concentration and the number of macrophages decreased. 
The CM added to the normal bone marrow cultures contains a 
heterogenous mixture of growth factors capable of stimulating various 
cell types and, in some instances, macrophages and not mast cells have 
been the major cell type growing in culture (unpublished observation). 
Culture conditions during CM production can drive the T cells to 
produce factors favouring macrophage growth and differentiation. It 
may be that dexamethasone inhibits the responsiveness of macrophages 
to growth factors present in the CM so that neutrophil growth and 
differentiation is favoured. It has been observed that systemic 
glucocorticoid treatment induced monocytopenia (Parrillo and Fauci, 
1978) and neutrophilia (Parrillo and Fauci, 1979) in humans. The 
mechanisms of these actions have not been elucidated but increased
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release of neutrophils by the bone marrow has been observed (Parrillo 
and Fauci, 1979). There are obviously many complicated regulatory 
circuits involved in haemopoiesis, and the effects of glucocorticoids 
on the different cell types have still to be unravelled. Perhaps the 
culture system described in this thesis could be utilized to 
investigate these various effects.
The present study also throws light on the findings of King et al 
(1985), who observed that methylprednisolone treatment causedthe 
depletion of mature MMC and of RMCPII from the rat jejunum. Addition 
of dexamethasone to 3 week old rat bone marrow cultures which comprise 
>90% mast cells did not, however, in the continuing presence of CM, 
cause depletion of these cells nor depletion of RMCPII and the cells 
maintained their well developed granular morphology. Collating these 
in vivo and in vitro data, it would seem that the effects of 
glucocorticoids on MMC are two-fold: firstly, they inhibit the
production of MMC growth factor(s) on which the in vitro generated 
cells are absolutely dependent for their growth and differentiation 
and secondly, they act directly on the mast cells themselves 
inhibiting the normal pattern of granule formation. If the 
hyperplasia of MMC and their persistence in the parasitised gut is due 
to the production of MMC growth factors by T-cells, then treatment of 
these animals with glucocorticoids would cause factor production to 
cease or be at too low a level to sustain or stimulate and maintain 
the population of MMC or their precursors. In addition, the drug also 
acts on the MMC precursor directly inhibiting development. These 
observations go some way to providing an explanation for the 
disappearance of MMC from the gut of corticosteroid treated rats.
It is important to note the usefulness of the in vitro culture
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system in investigating the phenomena found in vivo. It enables 
dissection of the responses to reveal the component parts of an 
integrated response, especially in this particular case where 
dexamethasone is acting on different cell types which vary the immune 
response.
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SECTION 2
Characteristics of mast cells grown in vitro
from normal rat bone marrow
Introduction
In the previous section it was shown that cells with the staining 
characteristics of mast cells grow and differentiate in normal rat 
bone marrow cultures stimulated with CM obtained from the MLN cells of 
Nb. infected rats activated in vitro by Con-A. The staining 
characteristics of the mature cultured mast cells have been described 
by Haig (1982; Haig et al, 1982). A detailed morphological and 
histochemical analysis of the developing cultured mast cells was 
undertaken, using light and electron microscopy.
In the rat, two populations of mast cells have been demonstrated. 
Cytochemical distinction between CTMC found in skin, muscle and 
peritoneal cavity, and MMC which predominate in the mucosa of the 
gastrointestinal tract, is based on the absence of granule heparin in 
MMC, and on the failure to detect MMC glycosaminoglycans in formalin 
fixed tissues (Enerback, 1981; Newlands et al, 1984). An alternative 
approach to identifying mast cell subsets is to determine the 
proteinase phenotype of mast cell granules. Biochemical studies have 
shown that RMCPI predominates in CTMC and RMCPII in MMC (Woodbury et 
al, 1978b) and more recently immunohistochemical analysis has 
confirmed that RMCPII is located exclusively in cells of the MMC 
phenotype and RMCPI is present in CTMC (Gibson and Miller, 1986). 
Using the above mentioned criteria, the in vitro cultured mast cells 
were compared to the mast cells identified in vivo.
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Chapter j5
Time course of mast cell development in vitro
by light and electron microscopy
Experiment 11
In order to obtain as many cells as possible for analysis, bulk 
cultures were set up as described in the Materials and Methods, using 
25% of a known potent CM produced from, MLN cells from Nb. infected
resuspended with fresh nutrient medium containing CM, this was 
repeated at least every 7 days or as required as assessed by the pH of 
the medium. Aliquots were removed from the flasks every 2 days and 
cytocentrifuge preparations made from the cell culture samples. Some
4% buffered neutral formalin, methanol or, Carnoy's fluid, and 
subsequently stained with either toluidine blue or astra blue/safranin 
according to the Materials and Methods. Aliquots of cells were also 
taken for examination by electron microscopy and were processed 
according to the Materials and Methods.
Results
Leishman staining
Figure 9a shows normal bone marrow cells stained with Leishman, 
in the centre are a number of mast cells with granules stained an 
intense deep purple-black colour, these have the appearance of the 
classic CTMC obtained from peritoneal washings (Figure 13a). Also 
present are neutrophils, eosinophils and various other haemopoietic 
precursors. After culturing bone marrow for 2 days, cells with sparse 
granulation appeared and became progressively more granulated with 
time (Figures 9b-g). The CTMC were not stimulated to grow and could 
not be maintained in culture much past day 7, when one or two could
After 7 days, the BM cells were pelleted and
of the slides were stained with Leishman and some were fixed in either
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Figure 9a: Cytospin preparation of normal bone marrow before
culture and stained with Leishman (x500). At the centre are densely 
stained mast cells.
Figure 9b: Cytospin preparation of normal bone marrow cells after
2 days in culture. Note the sparse granulation of the cultured mast 
cells (arrows), and the mitotic figure (m). Leishman stain (x500).
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Figure 9. c d: Cytocentrifuge preparations of cultured bone marrow
harvested on day 4 (c) and day 6 (d) of culture. The cells become 
more granulated with time (arrows). Note the residual CTMC (open 
arrow) in the day 6 culture. Leishman stain (x500).
Figure 9e: Leishman stained cytocentrifuge preparation of a normal
bone marrow culture harvested on day 8. The clump of mast cells is 
typical of the cell formation seen at this stage of culture, 
macrophages (m) being the other major cell type (x500).
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Figure 9f: Cytocentrifuge preparation of a normal bone marrow
culture, day 10 after plating. The mast cells are heavily granulated. 
Note the heterogeneity of granule size within the population of 
cells. Leishman stain (x500).
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Figure 9g: Normal bone marrow culture day 16 after plating. Mast
cells show the characteristic purple granules and eccentrically placed 
nucleus. A large macrophage is also present (m). Leishman stain 
(x500).
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still be seen at this time (Figure 9e). Eosinophils, 
monocytes/macrophages and neutrophils (but not lymphoid or erythroid 
cells) were also stimulated by CM in these cultures for a short period 
but disappeared approximately by day 10 of culture . Cultures refed 
and restimulated were, by 2-3 weeks, composed of relatively pure 
populations (>99%) of heavily granulated mast cells (Figure 9g) which 
were maintained for at least 8  weeks in the presence of CM. The only 
remaining contaminating cells were macrophages (Figure 9g). Cultured 
mast cells were larger than the other granulocytes and had large round 
or oval eccentric nuclei. Basophilic cytoplasmic granules of variable 
size and number were visible and stained deep blue-purple in colour 
with Leishman's stain. By comparison, identically stained peritoneal 
exudate mast cells appeared densely granulated, with granules often 
obscuring the nucleus (Figure 13a). The granules appeared smaller and 
more uniform and stained an intense deep purple-black colour.
Toluidine blue staining
Peritoneal exudate cells fixed by any of the three fixatives, 
buffered neutral formalin, methanol or Camoy's, displayed a mass of 
purple metachromatically stained granules in the cytoplasm which 
obscured the nucleus (Figure 10a). Cultured cells harvested on day 14 
of culture were only clearly stained when fixed in either methanol or 
Carnoy's. They had readily visible pale blue nuclei and purple 
metachromatically stained granules which were much sparser than those 
of the peritoneal exudate cells (Figure 10b).
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Figure 10a: Toluidine blue stained mast cells isolated from the
peritoneal cavity, showing characteristic purple-black metachromasia 
of the granules. (x625).
Figure 10b: Methanol fixed cultured bone marrow cells, day 14 after
plating, stained with toluidine blue (pH 0.5). These cells are 
sparsely granulated compared to mast cells from peritoneal cavity but 
also display metachromasia (x1250).
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Astra blue/safranin
The granules of mast cells in normal bone marrow displayed a 
spectrum of staining with astra blue/safranin from exclusively blue 
through a mixture of both blue and orange to exclusively orange 
granules (Figures 11a-c). All three fixatives gave similar results. 
The staining characteristics of marrow mast cells were identical to 
those of peritoneal mast cells (Figure 13b).
The sparsely granulated cells which appeared in the culture from 
day 2 onwards were stained with astra blue/safranin dyes only when 
fixed in either methanol or Camoy's. They could not be stained after 
fixation in neutral buffered formalin. On Day 2 of culture the cells 
had only very few astra blue positive granules and the nuclei stained 
pale pink with safranin (Figure 12a). By day 6 of culture, the mast 
cells were much more granulated (Figure 12b). The cells were 
heterogenous with regard to size and shape and displayed various 
degrees of granularity (Figure 12b). Mature cultured mast cells, day 
14 after plating showed heavy granulation (Figure 12c). The granules 
displayed the typical heterogeneity of size associated with MMC. The 
granules stained positively with astra blue throughout the culture 
period and at no time took up safranin in preference to astra blue in 
contrast to the CTMC.
Electron microscopy
By day 2 of culture, blast cells could be seen which contained 
occasional small electron-dense inclusions dispersed in their abundant 
cytoplasm particularly in the vicinity of the Golgi apparatus (Figure 
14a). Larger vesicles of varying shapes which contained more 
electron-lucent granular material were also occasionally present
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(Figure 14a). The nuclei which were large, oval or bean-shaped 
demonstrated margination of the heterochromatin and usually contained 
a prominent nucleolus. The cell membrane was characterised by some 
small stout pseudopodia. Macrophages were very abundant at this point 
in culture and could be differentiated from the early mast cells by 
the numerous electron-lucent cytoplasmic inclusions of varying sizes, 
and occasional lipid droplets. Their cytoplasm was also paler because 
they contained fewer free ribosomes and polyribosomes than maturing 
mast cells. However these macrophages contained relatively few 
lysosomal and residual bodies (Figure 14b).
By day 4 of culture, cells with a number of large electron-dense 
granules in their cytoplasm were present (Figure 14c). The increase 
in granule content was accompanied by a decrease in the volume of the 
other cytoplasmic organelles. The perinuclear Golgi apparatus was 
usually still a characteristic feature of these cells. The 
heterogeneity of the granule matrix was of interest at this stage in 
culture (Figure 14d). They ranged in size and electron-density; some 
very irregular vacuoles contained very electron-lucent particulate or 
condensed granular material whereas other generally smaller granules 
were electron-opaque. The delineating membrane could be seen quite 
clearly in some of the granules (Figure 14d). There appeared to be a 
series of vacuoles in varying stages of maturation. The smallest 
membrane bound vesicular structures possessed a granular matrix of low 
electron density. As the granules enlarged, their matrix became more 
electron-dense and often contained circular inclusions. They were 
usually spherical in profile (Figure 14d).
In more mature cultures of 3-4 weeks of age, the mast cell's
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cytoplasm was full of electron-dense granules at the expense of most 
other organelles (Figures 14e-h) such as Golgi complexes and rough 
endoplasmic reticulum. The granules were more pleomorphic than in 
previous stages. Most of the granules were more or less uniformly 
electron-dense. However, some granules near the plasma membrane 
showed evidence of dissolution of their matrix. Some of the granules 
at these later stages of culture also exhibited a fibrillar or 
crystalline substructure to their matrix. Electron-lucent halos or 
demilunes were also present around some granules. However it is 
unclear whether these are artefactual or not since impregnation of 
large cell pellets with resin was often a problem.
The peritoneal mast cell (CTMC) contained granules of much more 
uniform size and shape than those of the cultured mast cells (Figure 
15). The granules of this cell were also very electron-opaque.
Discussion
Basophilic granular cells were described growing in liquid bone 
marrow cultures in the presence of CM made from IMLN cells from Nb. 
infected rats stimulated in vitro by Nb. antigen or Con-A (Haig, 1982; 
Haig et al, 1982; Section 1). It appeared that they exhibited some of 
the characteristics of MMC (Haig, 1982; Haig et al, 1982) and so a 
more detailed analysis of their histological and ultrastructural 
development in culture was undertaken.
The mature cultured cells exhibited the generally accepted 
criteria for the definition of mast cells. When stained with 
Leishman, the cells showed a pale round eccentrically placed nucleus 
with well defined basophilic staining granules. In addition, when
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Figure 11: Astra blue/safranin stained normal bone marrow displaying
CTMC in various stages of maturity, from the immature cell stained 
exclusively blue (a), to the intermediate cell (b) stained both blue 
and orange, to (c) the most mature cell stained exclusively orange (a- 
c) (x1250).
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Figure 1 2: Methanol fixed cultured bone marrow cells stained with
astra blue/safranin on day 2 (a) x320 (blue filter), day 6 (b) x500 
(blue filter) and day 14 (c) x1250. Note the progressive granulation 
of the cells as the cultures mature and that none of the mast cell 
granules stain with safranin.
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Figure 13a: Leishman stained mast cells isolated from the peritoneal
cavity. The cells are so heavily granulated the nucleus is obscured 
in many of the cells. (x1250).
m
Figure 13b: Mast cells isolated from the peritoneal cavity and
stained in the astra blue/safranin sequence. Note the spectrum of 
staining of the granules from astra blue positive, to a mixture of 
both astra blue and safranin, to staining exclusively with safranin 
(x1250).
aFigure 14a: Electron micrograph of normal bone marrow cells 2 days
after plating, showing a possible immature mast cell with a large 
nucleus and prominent nucleolus. A few small electron-dense granules 
are indicated (arrows) adjacent to the Golgi apparatus (G). The 
cytoplasm contains several profiles of rough endoplasmic reticulum 
(x5,700).
Figure 14b: Electron micrograph of day 2 culture showing a variety of
cell types including an eosinophil (E), a polymorphonuclear leukocyte 
(P) and macrophage (M). The latter are characterised by large numbers 
of electron-lucent phagolysosomes, and complex nuclear profiles 
(x7,600).
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Figure 1 4c: Electron micrograph of cultured mast cell day 4 after
plating. Note the prominant perinuclear Golgi apparatus (G) and 
numerous granules of variable morphology including several large 
electron-lucent membrane bound vesicles (V), some containing 
flocculent material (x15,500).
Figure 1 4d: Higher power of boxed area from Fig.1 4c showing more
detail of the membrane bound electron-dense granules. Possible stages 
of granule maturation (1-4). (x57,000).
Figure 14e: Electron micrograph of normal bone marrow culture day 24
after plating illustrating several mature mast cells. The granules 
are numerous and of varying sizes, shapes and electron densities. 
Note the numerous filopodia on the cell membranes (x4,200).
f
Figure 1 4f: Higher power of mast cell from day 24 culture, to show
the plecmorphic nature of the granules (x12,000).
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Figure 14g: Electron micrograph of day 28 cultured mast cells which
are replete with large electron-dense granules (x4,200).
Figure 14h: Higher power of Fig.14g illustrating the range in
dimensions and morphological appearance of the granules. Electron- 
lucent holes around some of the granules could possibly be 
artefactual. Other identifiable cytoplasmic organelles are infrequent 
(x12,000).
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Figure 15; Electron micrograph of an isolated CTMC from the 
peritoneal cavity. Note the more uniform size and osmophilia of the 
granules which also have a more circular profile compared to the 
cultured mast cell. Note the prominant Golgi apparatus (G) and 
centriole (arrow). (x9,000).
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stained with toluidine blue at pH 0.5, the granules showed 
metachromasia, this has been, historically, the distinguishing feature 
of the mast cell. Thus the cultured cells shared with the MMC and 
CTMC the basic staining characteristic of mast cells and indicated 
that they contained sulphated glycosaminoglycans (GAG) in the granules 
(Haig, 1982; Haig et al, 1982).
The special fixation techniques required to demonstrate MMC 
(Enerback, 1966a) were also found to be necessary for the 
demonstration of cultured mast cells throughout their period of 
development in vitro, with both toluidine blue staining and astra 
blue/safranin staining. It had been originally suggested that the 
failure of normal aldehyde fixatives to preserve the stainability of 
MMC granules was due to the extraction of a soluble GAG by the 
fixative rather than to a blocking of dye binding groups of the GAG by 
the aldehyde (Enerback, 1966a). Wingren and Enerback (1983) have 
found that dye is taken up by MMC in conventionally fixed tissues 
after staining for 5-7 days or after trypsinization of the tissue 
sections, thus confirming Miller and Walshaw's (1972) observation that 
aldehyde fixation of MMC granule protein presents a barrier to the 
diffusion of stain.
The cultured mast cell granules at all stages of development , 
when appropriately fixed, stained positively with astra blue at pH 
0.3, the nuclei staining pink with safranin counterstain as did the 
mature in vitro-derived mast cells (Haig, 1982; Haig et al, 1982). 
CTMC granules, on the other hand, took up the dye safranin 
preferentially. This is in agreement with the studies of Enerback 
(1966b) who showed that MMC took up the blue stain exclusively whereas 
identically fixed and stained dermal mast cells showed a preferential
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uptake of safranin: this distinction is based on granule contents of
weakly and strongly sulphated mucopolysaccharides respectively. The 
indication from these findings that the proteoglycan of MMC has a 
different structure to that of CTMC was confirmed by Tas and Bemdsen 
(1977) who used a microspectrophotometric technique to demonstrate an 
absence of significant amounts of heparin in MMC and the presence of a 
lower sulphated GAG. This GAG has been identified as an oversulphated 
galactosaminoglycan (Enerback et al, 1985). Preliminary studies have 
identified an oversulphated chondroitin sulphate as the major GAG 
present in the mature cultured mast cells (R. Stevens, personal 
communication) thus agreeing with the previous data of Enerback et al. 
Analysis of the cultured murine mast cells has shown that they also 
contain an oversulphated chondroitin sulphate as opposed to heparin 
(Razin, Stevens, Akiyama, Schmid and Austen, 1982). Rat peritoneal 
mast cells may show a mixed blue/red granulation with astra 
blue/safranin, reflecting mixed granule contents of weakly and 
strongly sulphated glycosaminoglycans, respectively. Maturation of 
rat peritoneal mast cells involves an ultrastructural reorganisation 
of the granule matrices. The process of granule formation reflecting 
the synthesis and accumulation of a heparin precursor in the astra 
blue positive granules followed by N-sulfation of these precursors 
associated with a shift to safranin staining (Combs, Lagunoff and 
Benditt, 1965). No equivalent granule reorganisation occurs during 
the progression of rat intestinal mast cells in vivo (Miller, 1980) or 
in vitro (Haig, 1982; Haig et al, 1982). The newly developing mast 
cells in culture continue to demonstrate astra blue staining granules 
throughout the period of culture. Using the criteria of proteoglycan
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fixation and staining to distinguish the mast cell subtypes present in 
the rat has proven to be difficult as the CTMC displays a range of 
proteoglycan phenotypes (Combs, Lagunoff and Benditt, 1965). 
According to the aforementioned criteria, in vivo and in vitro-derived 
MMC show the staining characteristics of immature CTMC.
After 4 days of culture, the granulated cells which appeared in 
normal rat bone marrow cultures exhibited some of the ultrastructural 
characteristics previously attributed to MMC by iri vivo studies 
(Murray, Miller and Jarrett, 1968; Miller, 1971a,b; Enerback and 
Lundin, 1974) as well as resembling MMC isolated from the intestine of 
the rat (Befus et al, 1982). The in vivo-derived MMC are smaller than 
the CTMC isolated from the peritoneal cavity and contain granules 
which are much more variable in size than those of CTMC, and although 
many granules are homogenously electron-dense, others show various 
degrees of electron-lucency. The nucleus of MMC in situ or isolated 
from the rat intestine is variable in shape, sometimes being oval, or 
it can be irregular with indentations. From as early as day 4 of 
culture, cells with electron-dense and electron-lucent granules were 
apparent. The granules displayed the marked variation seen in the in 
vivo-derived MMC with regard to size and shape. The nuclei of 
cultured MMC were generally ovoid or reniform and nucleoli were 
commonly present, a feature often seen in MMC of rat small intestine 
(Miller, 1971a). It has already been shown that MMC derived from 3 
week old normal bone marrow cultures have the ultrastructural features 
of in vivo-derived MMC (Haig et al, 1982) and this is confirmed in the 
present study.
Mastoblasts were present in the rat intestine from day 10 after 
infection with Nb.. These cells had abundant cytoplasm in which
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there were numerous ribosomal aggregates as well as a few profiles of 
rough endoplasmic reticulum. Small electron-dense granules were 
present in the area of the Golgi apparatus. It was suggested that 
these cells gave rise to MMC found in rat intestine (Miller, 1971a). 
It was observed that a few electron-dense granules were present in 
cells with a blast-like appearance by day 2 of normal bone marrow 
culture. These cells had abundant cytoplasm containing many free 
ribosomes and polyribosomes and a well developed Golgi apparatus. The 
nuclei of these cells was large and contained a prominent nucleolus. 
The cultured mast cells at this time therefore bore a resemblance to 
the "mastoblast" referred to by Miller (1971a). The pattern of 
maturation of the cultured mast cells whereby the granules eventually 
filled the cytoplasm at the expense of the other cytoplasmic 
organelles seemed to follow that described for both CTMC (Combs, 1966) 
and intestinal MMC (Miller, 1971a). The prominant Golgi apparatus and 
numerous fragments of rough endoplasmic reticulum which were seen in 
the early developing mast cells of all types being reduced by the 
formation of large and numerous granules.
It is not clear if the heterogeneity of the granule matrix 
observed during development of the cultured mast cells was due to the 
process of maturation of the granules or if discharge of the matrix 
was occurring. In CTMC progranules fuse to form dense aggregates 
which become precursors of the mast cell granule (Combs, 1966). 
However, no aggregates of this type were seen in the intestinal MMC 
(Miller, 1971a). Instead the majority of the granules in the 
maturing cell were large and had electron-dense matrices, although 
progranules were seen to fuse with large granules. Dense progranule­
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like structures were evident within the borders of developing cultured 
mast cells (Figure 14d). Ultrastructural alterations of the granule 
matrices has been described during the discharge process of MMC 
(Murray, Miller and Jarrett, 1968). The intracellular discharge 
observed by Miller (1971b) where the perigranular membrane breakdown 
was followed by a gradual loss of matrix which became less dense and 
more granular, eventually disappearing, and leaving paracrystalline 
structures in empty vacuoles, was observed in cultured mast cells 
harvested throughout the period of culture. It is probable that both 
formation and discharge of granules is being observed in the cultured 
mast cells. The variable morphology of the granule matrix could be 
associated with the secretion of RMCPII into the culture supernatant 
(Chapter 6) as MMC can secrete granule bound substances without 
apparently degranulating. The possibility that the observations are 
artefactual due to the processing involved for electron microscopy 
cannout be ruled out.
There was difficulty identifying the cultured mast cells at early 
stages of development when few granules were present, and as well as 
this, the precursor cells from which these putative MMC developed were 
not readily identifiable. In order to identify these immature mast 
cells it is proposed to study them at both light and electron 
microscopic level using an immunogold technique. Monospecific F(ab' ) 2  
antibodies raised against the specific MMC marker RMCPII (see Chapter 
6) will be used to label the cells and this will be visualised using a 
gold conjugated anti-antibody. The localisation of RMCPII within the 
granules of the developing cultured mast cell would identify these 
cells categorically as MMC and provide a marker to investigate their 
development both in vivo and in vitro.
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The newly developing mast cells in culture had the fixation and 
staining characteristics of the mature MMC cultured in vitro by Haig 
et al (1982) and bore the features of in vivo-derived MMC rather than 
CTMC. The culture system provides an opportunity to produce MMC in 
sufficient numbers to characterise them more fully.
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Chapter 6_
Analysis of mast cell granule proteinases 
in normal rat bone marrow cultures
Introduction
Cytochemical studies of mast cell glycosaminoglycans have 
detected two major subpopulations of mast cells in the rat: CTMC
found in skin, muscle and peritoneal cavity, and MMC which predominate 
in the mucosa of the gastrointestinal tract (Enerback, 1981). MMC 
glycosaminoglycans cannot be detected in formalin-fixed tissues and 
this forms the basis for the cytochemical distinction between CTMC and 
MMC (Enerback, 1981; Newlands, Huntley and Miller, 1984). Clearly, 
neither of these techniques adequately defines mast cell 
heterogeneity. By determining the proteinase phenotype of the mast 
cell granules, an alternative approach to identifying mast cell 
subsets has been found. RMCPI has been shown to be predominant in 
CTMC by biochemical analysis, whereas RMCPII predominates in MMC 
(Woodbury et al, 1978b). Immunohistochemical staining of rat tissues 
has shown that RMCPII is present only in MMC and RMCPI in CTMC (Gibson 
and Miller, 1986).
The cultured mast cells described in Section 1 have been shown to 
exhibit the morphological and biochemical properties of MMC (Haig et 
al, 1982, Chapter 5). Further analysis of the mast cells grown in 
culture from normal rat bone marrow was undertaken to investigate 
their proteinase content and phenotype.
Experiment 12
Bulk cultures of normal rat bone marrow were prepared according 
to the Materials and Methods. A time course study on the appearance 
of RMCPII in cell extracts and culture supernatants was performed. 
Cells and supernatants were harvested on days 2, 4, 6, 8, 10, 14 and
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30 of culture. Extracts of cells were prepared for RMCPII analysis by 
the 'capture' ELISA method according to the Materials and Methods.
Results
RMCPII was detected in the cultured cell extracts in increasing 
amounts from day 2 of culture onwards (Table 11). This increase was 
also reflected in the amount of RMCPII being secreted into the culture 
supernatant. Thus the RMCPII levels in cell extracts and supernatants 
paralleled the increase and decline of total mast cell numbers in the 
culture. The cell kinetics followed the same pattern as those shown 
previously (Section 1, Chapter 1) with the total cell and mast cell 
numbers increasing within 7 days and levelling off between days 10 and 
14. After 3 weeks in culture the cells declined in number from the 
peak values of day 10, and stabilised at around 5 x 1 0 ^  per ml. The 
RMCPII content of the cells increased as they became more granulated 
and more mature (Table 11).
Experiment 13
The phenotype of the cultured cells was characterised using 
monospecific F(ab' ) 2 antibodies which were employed to demonstrate, 
immunohistochemically, the presence of RMCPI and RMCPII. For this 
purpose cells were harvested from bulk bone marrow cultures on days 7, 
16 and 30 of culture. Total cell counts were performed and cytospin 
preparations were made. The slides were then fixed in methanol, 
Carnoy's or 4% paraformaldehyde, and stored at ~20°C. Peritoneal 
exudate cells were obtained by peritoneal lavage of F344 rats (a pool 
of 3 animals was used per experiment). A total cell count was
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Table 11; Time course of RMCPII content and secretion by cultured
mast cells
Day of 
culture
Total cells 
x10 /ml
Mast cells 
x10 /ml 
(% total culture)
RMCPII content 
cell extract 
(pg/cell)
RMCPII content 
supernatant 
(jig/ml)
0 25 0.2 (0.9)* <1 <0.01
2 32 7.0 (22.0) 7 0.30
4 79 36.3 (46.0) 15 1.50
6 92 43.7 (47.5) 22 2.20
8 135 68.5 (50.8) 28 2.51
10 137 77.1 (56.3) 32 3.10
14 121 80.0 (66.1) 35 3.15
30 51 50.1 (98.2) 42 2.56
* Cells with staining characteristics of CIMC
130
performed and cytospin preparations were made and fixed as for the 
cultured cells.
RMCPI and RMCPII were demonstrated in the cell preparations using 
affinity purified rabbit Ffab'^ anti-RMCPI and anti-RMCPII which had 
been rendered monospecific for each enzyme by affinity chromatography 
and cross absorption (Gibson and Miller, 1986). Development was 
accomplished using sheep Fab anti-rabbit F(ab‘^ -peroxidase conjugate 
and 3-amino-9-ethyl carbazole as substrate (Newlands, Huntley and 
Miller, 1984) (for details, see Materials and Methods). The 
aforementioned procedure was carried out by Steve Gibson and George 
Newlands (Moredun Institute, Edinburgh) to whom I am most grateful. 
Toluidine blue (pH 0.5) and Leishman staining were also performed on 
the cytospin preparations. The numbers of mast cells stained with 
toluidine blue/Leishman were counted. Comparable slides were then 
assessed for numbers of mast cells stained with anti-RMCPI and anti- 
RMCPII after the immunoperoxidase reaction. Five fields of view were 
counted per slide with at least 100 cells counted per field. The 
results are expressed as a percentage of total cells counted per 
slide.
Results
On day 0 when the bone marrow was plated, cells containing RMCPII • 
were not present and those few mast cells (1.8% of total) which 
stained with toluidine blue had the histological appearance of CTMC 
and contained RMCPI exclusively (Table 12). By day 7, cells 
containing RMCPII made up almost half of the total culture with a 
small percentage of anti-RMCPI stained cells still remaining
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Table 12; Comparison of mast cell subsets stained with toluidine 
blue/Leishman, anti-RMCPI or anti-RMCPII in peritoneal 
exudate cells (PEC) and cultured normal bone marrow (NBM)
Day of 
culture
Cell
Type
% cells stained 
Tol. blue/Leishman
% cells stained 
anti-RMCPI
% cells stained 
anti-RMCPII
NA PEC 11.6 10.8 0
0 NBM 1.8 1.6 0
NA PEC 9.6 7.7 0
7 NBM 48.7 1.6 44.4
NA PEC 10.2 9.3 0
16 NBM 88.7 0 88.0
NA PEC 13.9 15.6 0
30 NBM 94.1 0 93.0
NA Not applicable
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Figure 16a &_ b: Peritoneal exudate cells stained by an
immunoperoxidase method utilising monospecific rabbit Ffab')? anti- 
RMCPI or II. a). anti-RMCPI (blue filter, x320); b). anti-RMCPII 
(x500). The CTMC stained exclusively with the anti-RMCPI antibodies.
Figure 16 c _& d: Normal bone marrow cells, day 7 after plating,
stained as above, c). anti-RMCPI (x500), these are residual CTMC 
(arrows). d). anti-RMCPII (x500), cultured mast cells stained 
exclusively by these antibodies.
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Figure 16e f^: Normal bone marrow cells, day 16 after plating,
stained as in Fig.16a-d. e). anti-RMCPI (blue filter, x320), no cells 
containing RMCPI remained in culture by this time, f). anti-RMCPII 
(x500), >88% of cultured cells contained RMCPII. Note the varying 
degrees of staining within the population (arrows).
g * h .
Figure 16g Ji h: Normal bone marrow cells, day 30 after plating,
stained as above, g). anti-RMCPI (x500), there were no remaining 
RMCPI containing cells at this stage of culture, h). anti-RMCPII 
(x500), >90% of cells in the culture stained with this antibody but 
again to varying degrees.
134
(Table 12, Figures 16c & d). The latter were residual CTMC present in 
the normal bone marrow but these had virtually disappeared within 7-10 
days in culture. Both the CTMC and cultured mast cells could be 
stained with the antibodies after fixation in all three fixatives 
tried, but methanol preserved the structure of the cells better than 
the Carnoy's fixative or paraformaldehyde. By day 16 of culture, 
RMCPII-containing cells made up >88% of the culture and no RMCPI 
positive staining cells remained (Figures 16e & f). The only 
remaining contaminating cells were macrophages. Cells stained by 
anti-RMCPII antibodies made up >90% of the culture by day 30 and, as 
with the cells taken from day 16 cultures, displayed varying degrees 
of staining (Figures 16g & h).
The connective tissue mast cells in peritoneal exudates stained 
with anti-RMCPI and this was used as the control (Figures 16a & b). 
The CTMC present in the day 7 culture were, like peritoneal mast 
cells, typically large cells densely packed with uniform granules. By 
comparison, the granules of the RMCPII-containing cells at day 7, 16 
and 30 of culture were sparser and varied in size (Figure 16).
Discussion
A mast cell protease which showed chymotrypsin-like activity was 
first characterized by Benditt and Arase (1959). Subsequently a mast 
cell enzyme which behaved similarly to trypsin was described (Glenner 
and Cohen, 1960). However, most interesting was the discovery that 
an intracellular serine protease isolated from rat small intestine 
differed from a similar enzyme isolated from skeletal muscle or liver 
(Katanuma, Kbminami, Kobayashi, Banno, Suzuki, Chichibu, Hamaguchi and
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Katsunuma, 1975). Woodbury and colleagues have demonstrated these 
variant serine proteases in the two types of rat mast cells (Woodbury, 
Gruzenski and Lagunoff, 1978b). RMCPI, originally isolated from 
skeletal muscle as mentioned above being identical to that 
subsequently isolated from peritoneal mast cells, and RMCPII, 
differing in solubility, structure and antigenicity from RMCPI, was 
localised to mast cells in the small intestine. The protease RMCPII 
appears to be the real hallmark of the MMC subtype in the rat and is 
contained in substantial amounts in the cultured mast cells. It is 
also secreted by them, without apparent degranulation,.into the 
culture fluid at detectable levels by day 2 of culture and in pg 
quantities/ml within 1 week of culture. This finding supports the 
proposal (Woodbury et al, 1984) that MMC have a secretory as well as a 
degranulatory function. Exactly what RMCPII is doing being produced 
and secreted in such quantities is not yet known but it has been shown 
to catabolize type IV collagen of basement membrane (Sage, Woodbury 
and Bornstein, 1979). Miller and colleagues have confirmed this 
(Miller, King, Gibson, Huntley, Newlands and Woodbury, 1986) and 
have presented evidence to suggest that RMCPII may be involved in the 
generation of mucosal epithelial permeability (King and Miller, 1984). 
As far as their involvement in the elimination of gut dwelling 
parasites is concerned, MMC may play a role by causing the enteric 
mucosal epithelium to be sloughed off and so exclude the parasites 
which live on or penetrate the epithelium.
Despite the 75% sequence identity in their 52 amino terminal 
residues, cross-reactivity between the enzymes RMCPI and II and their 
respective antibodies could not be detected on gel diffusion (Woodbury 
et al, 1978b) nor by ELISA (Miller et al, personal communication).
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However, a strong cross-reactivity was demonstrated when the enzymes 
were separated on SDS-PAGE under reducing conditions and transferred 
to nitrocellulose, and then probed with the same antibodies (Gibson 
and Miller, 1986). Affinity absorption procedures eliminated all 
cross-reactivity detectable by Western blot analysis. A definitive 
pattern of immunohistochemical localisation of each enzyme was 
revealed with RMCPII present only in the mast cells of the intestinal 
mucosa, and tracheal and bronchial epithelium. Mast cells in skin, 
ear pinna, tongue, tracheal submucosa and lung parenchyma contained 
uniquely RMCPI.
Using previously available criteria to distinguish MMC from CTMC 
(Enerback, 1981; Jarrett and Haig, 1984) it appeared that the mast 
cells growing in culture were of the mucosal type. However, none of 
these criteria on its own was sufficient to identify the cells as MMC 
with any degree of certainty. Having shown biochemically that the 
cultured mast cells contain and secrete RMCPII, it has been 
demonstrated immunohistochemically using monospecific Ffab1^  
antibodies that the cells which grew and differentiated in the normal 
bone marrow cultures were exclusively stained by anti-RMCPII, and 
RMCPI was present only in cells which by previous histochemical 
criteria had been defined as CTMC i.e. the peritoneal exudate cells 
and the mast cells present in normal bone marrow before culture.
Thus from the results detailed in this chapter it can be stated 
that the mast cells grown in culture from normal rat bone marrow 
stimulated by factors present in conditioned medium made from 
mesenteric lymph node cells from Nb. infected rats are in vitro 
analogues of the cells identified in vivo by comparable technique 
(Gibson and Miller, 1986) as mucosal mast cells.
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General Discussion
In this thesis a rat bone marrow culture system has been 
described, whereby normal bone marrow cells were cultured in vitro in 
the presence of conditioned medium to yield an almost pure population 
of mucosal mast cells, and this system provided an opportunity to look 
at these cells in detail and investigate the factors influencing their 
growth and differentiation.
Numerous reports have described the growth of mast cells in mouse 
haemopoietic tissue cultures stimulated with mitogen-activated 
splenocyte CM (Hasthorpe, 1980; Nabel et al, 1981; Razin, Cordon-Cardo 
and Good, 1981; Schrader et al, 1981; Tertian et al, 1981). Similarly 
it was shown that the cultured MMC in the rat are dependent on a 
factor produced by antigen or concanavalin-A stimulated T cells 
present in MLN taken from Nb.-infected rats (Haig et al, 1982;1983: 
Chapters 1 and 2).
It is clear from experiments in vivo that MMC precursors are 
strongly T cell-dependent for their hyperplasia in immune reactions 
and especially in helminth infection (Mayrhofer, 1979; Nawa and 
Miller, 1979). In vitro experiments involving nude rats show why this 
is the case (Haig et al, 1983; Chapter 2). CM made from rnu/rnu MLN 
does not contain growth stimulatory activity for MMC in normal or 
athymic bone marrow cultures. On the other hand, CM from rnu/+ or 
control (LIS x BN)F<j I MLN stimulates total and mast cell growth in 
both mu/+ and m u / m u  bone marrow cultures. In conjunction with the 
information that the m u / m u  genotype is associated with congenital 
aplasia of the thymus and a gross deficiency of mature T cells 
(Festing et al, 1978; Brooks et al, 1980), this experiment says two 
things: that MLN from rnu/rnu rats, having insufficient T cells,
simply does not produce MMC growth factor but that a population of
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bone marrow cells from these rats is capable of responding to the 
factor(s) if it is presented to them. Subsequently, the cell surface 
phenotype of the T cell responsible for producing the MMC growth 
factor(s) was established and the ce.lls found to belong to the 
helper/inducer subset (McMenamin, Jarrett and Sanderson, 1985; 
Chapter 3). This agreed with Nabel et al (1981) who found that murine 
mast cell growth factor activity was a product of mitogen or antigen- 
stimulated Thy1+, Lyt1+,2“ T cells, these also being of the 
helper/inducer subset.
Bone marrow-derived murine mast cells proliferate in the presence 
of the haemopoietic growth factor IL-3 (Ihle, Pepersack and Rebar, 
1981) which has been purified to homogeneity (Ihle et al, 1982; Bazill 
et al, 1983; Clark-Lewis, Kent and Schrader, 1984). The cDNA for IL-3 
has been cloned (Fung et al, 1984; Yokota et al, 1984) and the pure 
and expressed product shown to support the proliferation of not only 
T-dependent mast cells but also multipotential haemopoietic progenitor 
cells (Ihle et al, 1983; Hapel et al, 1985). More recently, murine 
mast cell growth stimulatory activity distinct from IL-3 has been 
identified and partially purified from the supernatant of the 
activated T-cell line Cl.Ly1+2“/9 (Lee et al, 1986). This mast cell 
growth factor supports only low levels of proliferation of several IL- 
3 dependent mast cell lines and synergistically enhances the growth of 
mast cells in the presence of IL-3. In addition, this clone produces 
B and T cell growth factor activity. The lymphokine with these 
activities has been collectively called IL-4 (Lee et al, 1986).
Fractionation of whole CM derived from mitogen-stimulated IMLN 
has revealed IL-3-like activity and this is based on several
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observations: firstly, rat CM stimulates the incorporation of H-
Thymidine into the IL-3 -dependent murine cell line, AC-2; secondly, 
both the AC-2 cell line growth supporting activity and MMC growth 
activity in CM are heat stable and elute from a DEAE sepharose column 
in the 5-10 mM buffer pH 8.3 breakthrough fraction (D.M. Haig, 
personal communication). Murine IL-3 behaves in a similar fashion 
after such treatment, as does the pure rat IL-3 obtained by the 
cloning of the rat IL-3 gene and expressed in non-human primate cells 
(Cohen, Hapel and Young, 1986). The "IL-3 enriched" fraction of rat 
CM, as well as retaining MMC growth factor activity, also supported 
the growth of multipotential colonies which is a typical property of 
IL-3.
In addition, a further fraction of rat CM was obtained which was 
capable of stimulating mature cultured MMC and maintaining the IL-3 
dependent cell line AC-2 and was separate and different from the IL-3 
activity (D.M. Haig, personal communication). This is interesting in 
the light of the findings in the murine system, where additional mast 
cell/T cell growth factor activity has been identified (Lee et al, 
1986; Smith and Rennick, 1986). Having shown that T cells can 
regulate the growth of mast cells through the production of IL-3 
(Clark-Lewis and Schrader, 1981; Nabel et al, 1981; Ihle, Keller, 
Henderson, Frederick and Palasyznski, 1982), it seems that mast cells 
and T cells are linked in a complex immunoregulatory circuit. The 
activities of the IL-4 lymphokine, as designated by Lee et al (1986), 
adds another dimension to the circuit since the latter may 
coordinately regulate aspects of mast cell and T cell growth and 
differentiation. It seems, therefore, that more than one factor is 
involved in the growth and differentiation of mast cells. Future
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experiments utilizing the culture system described in this thesis are 
planned to test the pure rat IL-3 obtained by expression of the cloned 
gene product to see if it has the ability to initiate and maintain the 
growth of MMC from normal rat bone marrow in a similar fashion to the 
CM produced by the mitogenic stimulation of MLN cells from Nb.- 
infected rats. The fractions obtained from the partial purification 
of whole CM will also be tested.
Whilst working with in vitro systems it must always be borne in 
mind how the results compare with those obtained in vivo. Evidence 
that IL-3 is released from activated T cells during immunological 
reactions in vivo is indirect, and has been based upon the observation 
of localised increases in numbers of mast cells and IL-3 from cells of 
the ipsilateral draining lymph node of mice injected in one footpad 
with KLH, but not from cells of the untreated contralateral node. 
Increases in IL-3 secreting T cells and MMC precursors were detected 
in draining but not distal lymph nodes following antigen stimulation 
of mice (Crapper, Clark-Lewis and Schrader, 1984) or parasitic 
infection of rats (Haig, Jarrett and Tas, 1984) although it is not 
certain this is the only factor active in the latter situation. 
However mice injected subcutaneously with the WEHI-3b IL-3 secreting 
tumour developed detectable circulating levels of IL-3 and this was 
associated with an increase in MMC precursors, megakaryocytes, and 
neutrophils in distal organs (Crapper, Clark-Lewis and Schrader, 1984; 
Crapper, Thomas and Schrader, 1984; Guy-Grand, Dy, Luffau and 
Vassalli, 1984). The experiments involving localised immune reactions 
of moderate intensity provided evidence that the effects of IL-3 were 
confined to the immediate vicinity of the activated T cells (Crapper,
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Clark-Lewis and Schrader, 1984; Haig, Jarrett and Tas, 1984). 
However, during Nb. infection of mice, IL-3 activity was transiently 
observed in the serum (Filho, Dy, Lebel, Luffau and Hamburger, 1983). 
This particular parasitic infection may have provided a stronger 
stimulus for IL-3 production, similarly induction of Graft-versus-host 
disease in mice induced vigorous and widespread activation of donor 
T cells reflected by the presence of IL-3 in the serum (Crapper and 
Schrader, 1986).
A general scheme has been proposed for MMC development in vivo 
(Haig, 1982; Crapper and Schrader, 1983; Guy-Grand et al, 1984; Haig, 
Jarrett and Tas, 1984). In rats and mice, MMC precursors in a 
morphologically unrecognisable form migrate via the blood to the 
tissues, principally the small intestine. These then differentiate 
into granulated MMC under as yet undefined local tissue influences. 
Since comparable numbers of MMC develop in T cell-depleted or a thymic 
animals, and in normal animals (Ruitenberg and Elgersma, 1976; 
Mayrhofer, 1979), T cell derived IL-3 may not be responsible for MMC 
recruitment under normal conditions. However, in a thymic animals the 
possibility of activity from other cell types or from a few residual T 
cells cannot be ruled out. Following helminth parasite infection, 
there is a marked increase in both the number of T cells producing IL- 
3 and MMC appearing in the small intestine and local lymph nodes (Guy- 
Grand et al, 1984; Haig, Jarrett and Tas, .1984) implicating IL-3 as 
the mediator of MMC hyperplasia. The IL-3 activity detected in the 
sera of Nb.-infected mice supports the biological importance of this 
molecule in helminth infection (Filho et al, 1983).
IL-3 acts on stem cells to expand populations of committed 
progenitors for eosinophil, megakaryocyte, neutrophil, macrophage and
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erythroid lineages in culture (Prystowsky, Otten, Naujokas, Vardiman, 
Ihle, Goldwasser and Fitch, 1984; Hapel et al, 1985; Rennick et al,
1985). Following helminth infection, an in vivo increase in MMC is 
almost invariably associated with recruitment of eosinophils, 
neutrophils, monocytes and lymphocytes to the parasitized tissue 
(Miller, 1984). All of these cell types have potential helminthicidal 
activities (Ogilvie, Love, Jarra and Brown, 1977; Capron, Dessaint, 
Haque and Capron, 1982) that might be regulated by MMC either by the 
elaboration of chemotactic factors (Wasserman, 1983) and/or by 
allowing the cells access to parasites via an IgE-mediated local 
immediate hypersensitivity reaction (Urquhart, Mulligan, Eadie and 
Jennings, 1965). Studies on T cell products including IL-3 generated 
during helminth infection has led to the conclusion that one of their 
principle actions is to stimulate production of MMC. Further 
investigations are required to reveal at which level of haemopoiesis 
these factors act to expand the pool of precursor cells involved in 
the local reaction.
It was observed that production of MMC growth factors was 
suppressed when IMLN cells were cultured in vitro in the presence of 
dexamethasone during CM production (Chapter 4). It had already been 
shown in vivo that mast cell hyperplasia was suppressed by the 
pretreatment of these animals with cortisone (Jarrett et al, 1967). A 
possible explanation for this could be that the treatment of these 
animals with glucocorticoids caused the factor production to be 
suppressed to such a low level that the population of MMC or their 
precursors could not be sustained or stimulated and maintained.. 
Since the MMC growth stimulatory activity in the rat has been shown to
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have certain properties in common with IL-3 (D.M. Haig, personal 
communication), these results lend further support to the evidence 
that IL-3 is one of the mediators of mast cell hyperplasia. 
Glucocorticoids also act on the MMC themselves inhibiting the normal 
pattern of granule formation (Chapter 4). These observations go some 
way to providing an explanation for the effects of glucocorticoids on 
MMC in vivo.
A particularly important point to consider in a study of mast 
cell differentiation is the relationship between CTMC and MMC. 
Although both CTMC and MMC are derived from precursors that reside in 
the bone marrow (Hatanaka, Kitamura and Nishimune, 1979; Kitamura, 
Matsuda and Hatanaka, 1979; Kitamura, Yokoyama, Matsuda, Ohno and 
Mori, 1981; Sonoda, Ohno and Kitamura, 1982; Crowle and Reed, 1984) it 
is not clear whether CTMC and MMC are the products of separate mast 
cell lineages or represent different stages in a single pathway of 
mast cell differentiation. To address this question, Nakano et al 
(1985) injected cultured murine mast cells, which expressed some 
phenotypic similarities to MMC, into different sites of mast cell 
deficient mice WBB6 F^  -W/Wv and observed that connective tissues were 
subsequently populated by CTMC-like safranin positive cells of donor 
origin whereas the gastrointestinal mucosa contained alcian blue 
positive cells. It seemed, therefore, that cultured cells with the 
apparent phenotype of MMC were capable of giving rise to either CTMC 
or MMC depending on the in vivo microenvironment. However, since 
these cells were not cloned, there was the possibility that they 
contained two distinct sets of mast cell precursors and since the 
cultures were derived from bone marrow, one would expect them to 
contain haemopoietic stem cells capable of generating CTMC and MMC
r
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populations. Taking these issues into consideration, further studies 
were done where mast cell cultures were isolated in methyl cellulose, 
clones of cells were divided and injected into both the skin and 
stomach of individual mast cell-deficient WBB6 F-j-W/Wv mice. Mast 
cells arose in these tissues which seemed to have the features of CTMC 
and MMC depending on the anatomical location (Kobayashi, Nakano, 
Nakahata, Asai, Yagi, Tsuji, Komiyama, Akabane, Kojima and Kitamura,
1986). This work highlights some of the problems associated with the 
study of mast cell heterogeneity. Firstly, no definitive markers to 
demonstrate mast cell heterogeneity exist in the mouse, and the use of 
just one parameter, that of proteoglycan content, based on 
histological staining techniques, is not adequate. Secondly, and 
related to the above, is the fact that although cultured murine mast 
cells are compellingly similar to the alcian blue staining 
gastrointestinal population of mast cells which, in turn, may be 
analogues of rat MMC, this has not been proven.
From the experiments described above, the importance of the 
influence of the microenvironment on mast cell phenotype has been 
stressed. Further experiments to investigate this have been done in 
vitro (Levi-Schaffer, Austen, Caulfield, Hein, Bloes and Stevens, 
1985; Levi-Schaffer, Austen and Stevens, 1986). It was discovered 
that isolated rat CTMC would survive ex vivo for at least 30 days if 
they were co-cultured on monolayers of living mouse fibroblasts, but 
would die within 2  days if they were cultured alone or co-cultured 
with macrophages (Levi-Schaffer et al, 1985). It was concluded that 
living fibroblasts were required for survival of the in vivo 
differentiated CTMC as neither fibroblast CM nor the fibroblast matrix
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devoid of living fibroblasts supported the viability of this mast cell 
subtype. Effects of fibroblast co-culture on mouse bone marrow- 
derived mast cells has been investigated (Levi-Schaffer, Austen and 
Stevens, 1986). Cultured murine mast cells were cultured for up to 14 
days on a fibroblast layer. Although all of the granules of the 
starting cultured mast cells were, like MMC in vivo, alcian 
blue+/safranin“, almost all of the mast cells were observed to possess 
some granules which were safranin+ after 6  days in co-culture. After 
10-14 days in co-culture, all the mast cells had granules both alcian 
blue+/safranin+. The fibroblasts apparently induced a change in 
phenotype of the mast cell from MMC to CTMC.
The histological techniques based on the detection of 
glycosaminoglycans cannot be relied upon to give a true picture of 
mast cell heterogeneity. Since several genes are likely to regulate 
the synthesis of the highly complex proteoglycans in mast cell 
granules, and because local environmental factors seem to influence 
post-translational events in the synthesis and assembly of 
proteoglycans, histochemical analysis of mast cell granule 
glycosaminoglycans, however sophisticated, is likely to produce 
dubious phenotypic identification of mast cells. In the rat, an 
alternative approach is to determine the distribution of other major 
granule products, the chymotrypsin-like enzymes RMCPI and RMCPII. 
When monospecific anti-RMCPI and anti-RMCPII were applied in an 
immunohistochemical study of mast cell proteinases in the duodenum and 
respiratory tract, RMCPI and II were apparently located in different 
mast cell subsets (Gibson and Miller, 1986). The present study has 
shown the immature and mature mast cells grown in culture from normal 
rat bone marrow under the influence of CM contain RMCPII exclusively
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in their granules (McMenamin, Haig, Gibson, Newlands and Miller, 1986; 
Chapter 6 ). In order to determine if the apparent in vitro 
transformation of cultured murine mast cells to the CTMC phenotype 
also occurs in the rat, the bone marrow-derived rat MMC could be 
cultured on rat skin fibroblast layers and stained both with the 
monospecific antibodies raised against the proteinases, and 
histochemically to characterise granule glycosaminoglycans.
The questions posed with regard to the developmental and 
functional relationship of the different mast cell types have not been 
answered. The production of monoclonal antibodies against specific 
determinants on both MMC and CTMC, in conjunction with the markers 
provided by the specific protease and proteoglycan, histochemistry 
would be invaluable in studying the development of the mast cell 
lineage. Identification of MMC precursors by a membrane determinant 
would allow separation of these cells which could then be labelled for 
in vivo studies of their migratory properties. It is hoped to exploit 
the culture system described in this thesis to further investigate the 
many unanswered questions relating to rat mast cell heterogeneity.
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Appendices
Appendix 1_ (Figure 1)
Tabulated is the raw data used to generate Fig.1, hereafter only the mean of triplicate 
values are given as the individual results obtained in this experiment were typical of the 
spread of values one routinely observed.
Figure 1 (a): Total cell and mast cell growth in normal bone marrow cultures stimulated with CM
from NMLN stimulated with various concentrations of Con-A
CM Day
Counted
Total Cells 
x10 (Mean)
Actual Mast Cell/ 
Total Cell Counts
Mast Cells 
%
Mast Cells 
x10“4 (Mean)
IMU'J + nt. D4 46 132/602 22 10.12
allergen II 47 (47) 154/740 21 9.72 (10.15)II 48 162/744 22 10.45
D7 65 132/664 20 13.00it 80 (74) 232/832 28 22.40 (18.83)ii 77 220/801 27 21.10
NMLN + 2ug/ml D4 19 104/640 16 3.09
Con-A ii 25 (22) 120/634 19 3.16 (3.57)
ii 22 116/636 18 4.01
D7 25 124/640 19 4.84it 29 (27) 142/622 23 5.75 (5.53)
ii 27 138/620 22 6.01
NMLN + 5ug/ml D4 28 136/800 17 4.76
Con-A ii 36 (32) 68/612 11 3.96 (4.57)
ii 32 116/744 16 4.99
D7 58 200/672 30 17.40
ii 54 (55) 180/616 30 16.20 (16.87)
ii 55 202/654 31 17.00
NMLN + 10ug/ml D4 39 112/690 16 6.32
Con-A ii 26 (32) 118/692 17 4.43 (5.19)
ii 30 114/710 16 4.82
D7 26 160/544 29 7.54it 29 (28) 144/596 24 7.01 (7.33)
ii 28 150/564 27 7.45
Medium alone D4
ii
2
ii
£
3 Too few cells to evaluate
D7 3
ii 3
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Appendix 11 (Table 7a-c)
Repeat experiment of CM made from FACS-sorted IMLN cells labelled with 
Oxford monoclonal antibodies.
Source of CM
Total Cells 
(x1 0  )
Mast Cells 
(x1 0  )
Unfractionated IMLN cells 42 23.5
0X19-positive IMLN cells 61 37.3
0X19-negative IMLN cells 5 0 . 6
Medium alone 5 0.4
Unfractionated IMLN cells 72 33.1
W3/25-positive IMLN cells 65 25.4
W3/25-negative IMLN cells 6 0 . 8
Medium alone 4 0.4
Unfractionated IMLN cells 57 28.3
0X8-positive cells 5 0 . 2
0X8-negative cells 63 31.4
Medium alone 5 0.4
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